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Jorgensen and List introduced enantioselective α-amination of an aldehyde with an 
azodicarboxylate as the electrophile using L-proline enamine catalysis in 2002. Following 
borohydride reduction, the α-hydrazino alcohol was obtained in high yield (93-99%) and 
enantioselectivity (86-97%). Application of the enantioselective α-amination reaction to an 
acetal as a masked aldehyde was developed in our group recently, and in part I of this thesis 
results on extending this chemistry to the α-amination of N-protected hemiaminals from  
N-heterocycles are reported, in which it was found that the reaction only worked with the 
carbonyl group exo to the ring. In the case of the hemiaminal derived from N-Boc or N-CBz 
2-pyrrolidinone an amination with proline catalyst in acetonitrile over 3 days gave  
-aminated products in high ee (77-84%). N-N bond hydrogenolysis using Raney Nickel and 
hydrogen, followed by oxidation to the lactam afforded the N-protected α-amino lactam in 
high enantioselectivity (78% and 86%). 
In part II the development of a mild reduction of the N-N bond of the -hydrazino amination 
products of straight-chain aldehydes is reported. The corresponding oxazolidinone-
hydrazides are reduced to their oxazolidinones via a modified E1cB elimination using ethyl 
bromomalonate and potassium carbonate in acetonitrile. The reactions gave high yields  
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Chirality is a property of three-dimensional molecules, in which a molecule is chiral if its 
mirror image cannot be superimposed on the original. An example in everyday life is hands 
and feet. Such non-superimposable mirror images are known as enantiomers, and they have 
identical chemical and physical properties, but may react differently in biological systems, 
which are themselves chiral. The predominant structural feature that makes a molecule chiral 
is the lack of mirror-plane symmetry, although a more comprehensive analysis reveals the 
lack of SN symmetry (rotation-reflection symmetry). Enantiomers are characterised as 
stereoisomers, as they only differ in overall shape and not the connectivity of the atoms.1 The 
origin of chirality lies in the existence of stereogenic units or elements, for which there are 
three types as: central, axis and plane. Centrally chiral molecules possess an asymmetric 
tetrahedral carbon atom bearing four different groups or atoms, termed a stereogenic or chiral 
centre. Axially chiral molecules arise from the arrangement of different groups about a 
stereogenic axis, while planar chirality is the result of arranging groups with respect to a 
stereogenic plane, Figure 1.2 
 
Figure 1: Examples of central, axial and planar chiral molecules. 
Evidence for molecular chirality was discovered by the French chemist Louis Pasteur in 1848 
when he resolved the structure of sodium ammonium (±)-tartrate, a side product from wine 
production, through studies in search of the origin of the optical activity in the crystals, 
Figure 2.3,4 However, it wasn’t until 1874 that the Dutch chemist and winner of the first 
Nobel Prize in Chemistry, Jacobus Henricus van't Hoff, and French chemist Joseph Achille 




Le Bel, independently explained optical activity in terms of the tetrahedral arrangement of the 
atoms around a carbon centre.5 
 
Figure 2: The stucture of sodium ammonium (±)-tartrate. 
Chemists use two main stereochemical conventions to differentiate between enantiomers 
based on the assignment of a stereodescriptor to each enantiomer. The first and most used is 
the IUPAC Cahn–Ingold–Prelog (CIP) system named after Robert Sidney Cahn, Christopher 
Kelk Ingold and Vladimir Prelog. Here, a set of rules assign the absolute configuration of a 
stereogenic centre based on the rotational direction of atoms  around a chiral centre based on 
their relative priority, in which R denotes clockwise rotation (rectus) while S denotes anti-
clockwise (sinister).6,7 Figure 3 illustrates the system for lactic acid.  
 
Figure 3: CIP stereochemical convention. 
The second convention predates this by some fifty years or so and is the D- and L-convention 
due to the great German carbohydrate chemist Emil Fischer in the late 19th century. Before 
X-ray crystallography was developed chemists used glyceraldehyde as a standard that could 
be used as a comparison for deducing the configuration of other molecules based on their 
degradation to it. Fischer developed a 2D-convention in which the molecule is represented in 
a square planar fashion (glyceraldehyde as the prototype). In this the carbon backbone is 
placed vertically with the most oxidised carbon at the top, while the horizontal groups bear 
the H and OH substituents. The 2D-drawing has implied stereochemistry in which horizontal 
groups are taken as wedged while vertical groups are taken as dotted. Fischer designated the 
chiral centre of glyceraldehyde as D- or L- depending on whether the OH group was on the 
right or left respectively. He made the lucky guess, since it turned out to be correct, that the 
(+)-enantiomer of glyceraldehyde (based on optical rotation) was the D-isomer. This has been 




proved to be correct by X-Ray crystallography and is equivalent to the R-enantiomer 
according to the CIP system, Figure 4.8  
    
Figure 4: The Fischer convention. 
In addition, the physical parameter of optical activity [α]D is also used to assign a 
stereodescriptor to a particular enantiomer. This is based on the interaction of a chiral 
molecule with plane-polarized light in which the rotation of light to the right is given a (+) or 
dextrorotatory and to the left a (–) or laevorotatory descriptor.9 In the past, optical activity 
was the only measurable parameter for determining the enantiomeric purity of molecules but 
now there are techniques such as nuclear magnetic resonance (NMR) with a chiral shift 
reagent, and high pressure liquid chromatography (HPLC) using a chiral column.10 Equal 
quantities of two enantiomers in a mixture is called a racemic mixture, and this can be 
produced in a reaction from the addition of an achiral reagent to a prochiral centre in an 
achiral substrate. A classical example is the Strecker synthesis of amino acids as shown for 
acetaldehyde in Scheme 1. The reaction dates back to 1850, and involves reaction of an 
aldehyde with ammonium chloride to form an imine, which reacts with potassium cyanide 
(KCN) to produce an α-amino nitrile. The latter forms via a statistically equal addition to the 
two enantiotopic faces of the imine to afford a racemic mixture, which is then hydrolysed to 
the racemic α-amino acid, Scheme 1.11  





Scheme 1: The Strecker synthesis. 
Chiral molecules that are not mirror images of each other are called diastereoisomers, a term 
that is usually abbreviated to diastereomers, and these have more than one stereogenic unit. 
The Le Bel-van't Hoff rule states that a molecule with n stereogenic units can have up to 2n 
stereoisomers, as illustrated for Threonine in Figure 5.12  
 
 
Figure 5: 2n stereoisomers of Threonine. 
Unlike enantiomers, diastereomers do not have identical chemical and physical properties or 
optical rotations. The chemical names of diastereomers are also different whereas 
enantiomers are differentiated by (+)- and (-)- prefixes only. However, a chiral bioactive 
molecule can manifest a different biological activity of the enantiomers. This is because 
receptors are also chiral, and interactions between them proceed at the diastereo- level, which 
can manifest distinct physical outcomes. This trend is observed in all bioactive substances, 
which includes pharmaceuticals, insecticides, flavours and fragrances. The importance of 
producing chiral pharmaceuticals as single enantiomers continues to increase as researchers 
strive to find medicinal agents for diseases.13 
 




An example that led to the new legislation regarding the use of enantiomers in 
pharmaceuticals is that of thalidomide. Prescribed to pregnant women in the 1950’s for 
treatment of insomnia and morning sickness, the company in question (Chemie Grünenthal) 
were unaware that while the R-isomer was indeed effective as a sedative, the  
S-isomer had teratogenic properties, Figure 6. This resulted in children being born with 
multiple birth defects and the drug was withdrawn from the market.14,15 Table 1 shows other 
drugs whose enantiomers produce different effects.16 
 
Figure 6: S- and R-isomers of thalidomide. 
 
Table 1: List of drugs and effects of enantiomers 
Drug R-enantiomer S-enantiomer 
Ibuprofan Slow acting Fast acting 
Prozac Anti-depressant Helps against migraine 
Naproxen Liver poison Arthritis treatment 
Dopa Biologically inactive Parkinson’s disease 
 
 
There are methods that can be used to resolve racemates into their enantiomers such as direct 
preferential crystallization, the crystallization of diastereomeric salts or via kinetic resolution, 
but industrial production needs to consider methods that are fast and cost-effective.17 The 
progression to synthetically produce enantiomerically pure molecules led to the concept of 
asymmetric synthesis.  
 




1.2 Asymmetric synthesis 
Asymmetric synthesis refers to when a prochiral centre is converted into a chiral one such 
that there is a preference for stereogenicity at the new chiral centre. If the starting material is 
achiral, enantiomers may be produced in unequal amounts using a chiral reagent, while if the 
starting material is chiral, diastereomers can be produced in unequal amounts regardless of 
whether the reagent is chiral or not. The respective terminology applied is enantioselective 
and diastereoselective, which reflects selectivity by degree, i.e. is rarely 100% selective. 
Racemic mixtures arise because the transition states of the products have the same energy. 
Asymmetric synthesis involves the manipulation of reaction parameters in order to create 
transition states with diastereo- character that have different energies, resulting in the 
favouring in formation of one product over the other, Figure 7.18 Understandably, the various 
methodologies can be divided into diastereoselective and enantioselective types, and these 
will now be discussed in that order.19 
  
 
Figure 7: Equal transition state energies forming a racemic mixture (left), and unequal        
transition-state energies forming more of the desired product (right). 
 
1.2.1 Diastereoselective Asymmetric Synthesis 
Diastereoselctive asymmetric synthesis is the formation of one diastereomer in excess over 
the other. The degree of diastereoselectivity is measured by a diastereomeric excess (de) and 
is calculated by subtracting minor from major isomer percentages (D as a percentage), 
Equation 1.20  
 
Equation 1: The equation for diastereomeric excess. 
Alternatively, the two percentages of major and minor isomers can be reported as a 
diastereoisomeric ratio (dr), eg 95:5 dr = 90% de. A common type of this type of induction is 




promoted when chirality is present in the substrate to direct the induction, and such a type of 
process is termed a substrate-controlled one. More often than not the reagent is achiral, but in 
some cases a double asymmetric induction approach is utilised involving chirality in both 
substrate and reagent, which can give rise to match and mis-match outcomes. The following 
sections describe the various categories that the literature has assigned to manipulating 
existing chirality in the substrate for asymmetric synthesis. 
(i) Chiral pool 
Chiral pool synthesis refers to having the chirality originating from a natural source such as a 
sugar (carbohydrate) or amino acid. Here the chirality starts as a pure enantiomer even if 
there is more than one chiral centre, even if not all centres are carried through into the target. 
New chirality created from prochirality is engineered from existing chirality in the starting 
material, and synthesis often involves several steps and may require complex 
transformations, Scheme 2.21 Problems using this strategy arise when the desired enantiomer 
is not available as a natural product. An example of a chiral pool synthesis that does start 
from the correct enantiomer is shown in Scheme 2 in which 2-deoxy-D-ribose is converted 
into the insect pheromone Sulcatol, and as a pure enantiomer (R). The chiral centre in the 
product is derived from C-4 of the ribose, while the C-3 hydroxyl of the ribose is reductively 
removed, and its anomeric centre (C-1) converted into the olefin.  
 
 
Scheme 2: Chiral pool synthesis from a sugar. 
 
(ii) Chiral auxiliary 
Chiral auxiliaries are enantiomerically pure organic compounds that are used to control the 
diastereoselectivity of asymmetric reactions. The auxiliary is first covalently bonded to the 
achiral substrate making it chiral. A diastereoselective reaction then follows. Finally, the 
auxiliary is removed without changing the configuration of the newly-formed chiral centre or 




centres. The final product should be obtained in a high enantiomeric excess ultimately, and a 
good auxiliary is one that is easily removed intact and can thus be recycled, Scheme 3. 
Because the primary products are diastereomers, column chromatography or crystallization 
can often be used to separate them, but to be effective, drs need to be in the 90+ region.22   
Scheme 3 illustrates an example for the α-alkylation of an acid. 
 
Scheme 3: Asymmetric α-alkylation using a chiral auxiliary 
 
Although auxiliary-controlled methodology dates back to at least the 1970s, one of the most 
famous auxiliary-controlled methodologies is that developed in the early 1980s by David 
Evans at Harvard using oxazolidinones synthesized from amino acids using the chiral pool 
strategy, Scheme 4.  
 
Scheme 4: Synthesis of chiral auxiliary from (S)-valine. 
These have been used to bring about highly diastereoselective alkylations, as well as aldol 
and Diels-Alder reactions. Diastereoselectivity is achieved by the conformational preference 
of the auxiliary in the substrate intermediate (eg enolate), together with the shielding of one 
face of the prochiral functionality undergoing addition to create the new chiral centre through 
steric hindrance created by the chiral substituent attached to the auxiliary. Scheme 5 
illustrates these ideas in a standard alkylation sequence in which, following Z-enolate 
formation, chelation of the lithium with the oxazolidinone carbonyl creates a flat enolate in a 
chiral environment as a single conformer (s-cisC-N). Addition then proceeds from the face anti 
to the chiral substituent on the oxazolidinone ring. After reaction the auxiliary can be 
removed by SNAc hydrolysis, without racemising the newly formed centre.23 






Scheme 5: Directed electrophilic attack using Evans’ auxiliary. 
 
1.2.2 Enantioselective Asymmetric Synthesis 
Following the same trend as with diastereoselectivity, enantioselective asymmetric synthesis 
is the formation in a reaction of one enantiomer in excess over the other. The degree of 
enantioselectivity is measured by an enantiomeric excess (ee) and is recorded as a percentage, 
Equation 2, where E is the % of an enantiomer.24 This type of induction generally implies the 
use of a chiral reagent or catalyst transferring asymmetry to a prochiral substrate and is 
therefore categorized as reagent-controlled asymmetric induction. 
 
Equation 2: Equation for enantiomeric excess. 
 
There are a plethora of enantioselective methodologies in the modern synthesis literature, so 
the examples that follow are key ones designed to illustrate the key principles. 
 
(i) Epoxidation 
Enantioselective epoxidation is a highly useful reaction, since the chiral epoxide can be  
ring-opened to afford a variety of highly functionalized chiral building blocks (chirons) such 
as alcohols, diols and amino alcohols.25 In 1980, Karl Barry Sharpless developed a unique 
stereoselective epoxidation reaction that transforms primary and secondary allylic alcohols 
into epoxy alcohols,  known as the Sharpless epoxidation.26 Scheme 6 depicts the currently 
accepted transition-state model for this reaction involving the coordination of a chiral ligand, 
diethyl tartrate (DET), with a titanium catalyst, titanium tetra-isopropoxide, to form an active 




complex comprising two titanium atoms bridged by two tartrate ligands, which then reacts 
with an oxidizing agent tert-butyl hydroperoxide that displaces one of the isopropoxide 
ligands and one of the tartrate carbonyl groups. The allylic alcohol (here presented in a 
generalised form) then coordinates with the titanium by displacing a further isopropoxide 
ligand. The shape of the complex, which is depicted in Scheme 6 using L-(+)-DET, forces the 
reactive oxygen atom of the bound hydroperoxide to be delivered to a single face of the 
olefin. Also illustrated is the stereoselective outcome of the product which is controlled by 
the use of either L-(+)-DET which delivers the oxygen to the bottom face of the olefin, or  
D-(-)-DET which delivers the oxygen to the top face, according to the way structures are 
drawn. As shown, of significance here is the prior covalent attachment of reagent with 
substrate (here through a Ti-O bond) so that the reagent (an oxygen in this case) can be 
delivered selectively to one of the enantiotopic faces of the substrate (defined as such prior to 
co-ordination).  
 
Scheme 6: Sharpless epoxidation. 
 
Later in the early 1990s, the Jacobsen-Katsuki epoxidation was developed by Eric Jacobsen 
and Tsutomu Katsuki who independently reported the use of a chiral manganese(III)-salen 
catalyst to transform unfunctionalized cis-olefins. In contrast to Sharpless epoxidation this 
reaction relies solely on attractive electrostatic interactions (not involving any covalent bonds 
between substrate and reagent), and hence doesn’t require an adjacent functional group in the 
substrate like a hydroxyl group as in the Sharpless epoxidation case, Scheme 7.27 The 




(salen)Mn(V)-oxo complex has the two six-membered chelate rings distorted relative to one 
another in the transition state ensuring that the neighbouring t-butyl groups do not clash 
sterically. As a result of this positioning, the steric blocking of one face of the catalyst 
dominates more than the other forcing the incoming alkene to approach from the top in this 
case. Furthermore, the alkene approaches with the two R groups pointing away from the 
ligands, something that is not so clear-cut with a trans olefin.28 
 
 
Scheme 7: Jacobson-katsuki epoxidation. 
Another example is the Shi epoxidation developed in the mid 1990s by Yian Shi that utilizes 
a fructose-derived (chiral ketone) dioxirane catalyst that reacts with trans 1,2-di- and 
trisubstituted olefins as shown in Scheme 8 for E-stilbene. The catalyst is readily prepared by 
ketalization of D-fructose with acetone and perchloric acid followed by oxidation using 
pyridinium chlorochromate.29 The epoxidation proceeds via a dioxirane intermediate 
produced by reaction of oxone (potassium peroxymonosulfate) with the ketone carbonyl 
group, and transfer of oxygen to the alkene regenerates the ketone catalyst rendering the 
process catalytic.30 The enantioselectivity in the product is controlled by either going through 
a planar or spiro transition states, with minimised steric interaction between the alkene 
substituent and the dioxolane c ring. Also, the lone pair of the oxygen involved in the 
transition state interaction lends stability via interaction with the alkene π* orbital. In the 
transition state the alkene approaches the least-hindered equatorial oxygen of the dioxirane.31 





Scheme 8: Shi epoxidation. 
 
(ii) Diels-Alder Cycloaddition 
The Diels-Alder reaction is named after Otto P. H. Diels and his student Kurt Alder who 
made the discovery jointly in 1928 during their studies on the reaction of benzoquinone with 
cyclopentadiene, Scheme 9.32  
 
 
Scheme 9: Discovery of the Diels-Alder reaction. 
 
This reaction is termed a cycloaddition and occurs between a conjugated diene in a cis 
conformation and a substituted alkene referred to as the dienophile. The concerted transition 
state has a cyclic geometry shaped like a six-membered ring formed from the delocalization 
of π electrons. It involves no ions or free radicals and has no intermediate. Two new σ bonds 
and one π bond are created in the product and any stereochemistry observed in the reactants is 
retained in the product (stereospecific), as depicted in Scheme 10.33 
 
 





Scheme 10: Cycloaddition of a diene and dienophile. 
Following the discovery, researchers eventually developed Diels-Alder reactions using chiral 
Lewis acids for exploring the possibility of achieving enantioselectivity, in which Corey has 
made seminal contributions.34 Corey found that oxazaborolidines  derived from amino acids 
were particularly effective. Scheme 11 shows the case for a tryptophan-derived catalyst, 
where there is a proposed level of π-stacking between the π-excessive indole ring and the 
electron-deficient carbonyl group, rendering one face of the dienophile only as accessible for 
cycloaddition.35, 36 
 
Scheme 11: Oxazaborolidine use in Diels-Alder reaction. 
 
(iii) Dihydroxylation  
The use of osmium tetroxide (OsO4) in the cis-dihydroxylation of prochiral olefins dates back 
to 1912 when Hoffmann carried out a reaction in the presence of a chlorate salt that acted as 




an oxidant of the osmium once reacted, Scheme 12. About 30 years later, Rudolf Criegee and 
co-workers discovered that pyridine accelerated the rate of the reaction.37 
 
Scheme 12: Hoffmann dihydroxylation. 
The dihydroxylation proceeds through a cycloaddition reaction of OsO4 and the olefin to form 
an osmate ester, which is hydrolysed to give a 1,2-diol product. During this process osmium 
(VIII) is reduced to osmium (VI) necessitating the use of large amounts of this toxic and 
volatile reactant.38 The introduction of N-methyl morpholine-N-oxide (NMO) as a  
co-oxidant by the Upjohn Company assisted in this aspect by transforming the process into 
the use of catalytic OsO4 as shown in Scheme 13, and this paved the way for the development 
of the asymmetric dihydroxylation of olefins using a chiral ligand.39  
 
Scheme 13: Catalytic dihydroxylation. 
Early attempts with chiral ligands gave low ees owing to the instability of the complex, but 
eventually excellent ees could be realised using cinchona-derived ligands,40  and the use of a 
phthalazine spacer unit to create C-2 symmetry. The phthalazine spacer is attached to two 
chiral cinchona ligands (DHQ or DHQD – see Figure 8) placed on either side. Scheme 14 
illustrates the reaction with osmium being added as potassium-osmate (VI) dehydrate 
(K2Os2(OH)4) along  with potassium ferricyanide (K3Fe(CN)6) as the oxidant together with 
other additives that speed up the reaction.41  





Figure 8: Phthalazine-based ligands. 
 
 
Scheme 14: Sharpless dihydroxylation. 
A full description of the transition-state models accounting for enantioselectivity is complex 
and beyond the scope of this dissertation, but enantioselectivity relies on intermolecular 
interactions in a chiral environment.  
 (iv) Hydrogenation 
The hydrogenation of unsaturated compounds such as alkenes, ketones and imines into chiral 
alkanes, alcohols, amino acids and amines respectively with asymmetric induction has been 
one of the most intensely studied objectives in transition-metal catalyzed reactions. 
Enantioselective hydrogenation requires a chiral catalyst, which directs the addition of 
hydrogen across the double bond, and is best carried out on an alkene with a heteroatom 
neighbour.42 Rhodium and ruthenium-based complexes are the most commonly used catalysts 
and these require the presence of a chelating functionality in the substrate, whereas iridium-
based catalysts do not require coordination.43 Since hydrogenation only requires a minuscule 
amount of the catalyst (2 mol%), this method is widely used in industry to synthesize chiral 
compounds, such as the terpene citronellol (see Scheme 15 below), which is used in 
fragrances.  
 
Scheme 15: Hydrogenation using Ruthenium. 




The first examples of homogenous asymmetric hydrogenation were independently reported 
by Leopold Horner and William Knowles in the late 1960s by modifying Wilkinson’s 
catalyst RhCl(PPh3)3 with chiral monodentate phosphine ligands, but these provided poor 
enantioselectivities (8-15%).44 Later,  Henri Kagan and Knowles demonstrated that using 
bidentate chiral phosphine ligands improved enantioselectivity (88-96%). They each 
independently reported the C2-symmetric bisphosphine ligands, DIOP and DIPAMP, for 
rhodium-catalyzed asymmetric hydrogenation.45, 46  In 1980, Noyori and Takaya reported an 
atropisomeric (axial chirality about the bond joining the two naphthalene rings) C2-symmetric 
bisphosphine ligand, BINAP, which is now often used in ruthenium-based catalysis, Figure 
9.47 Researchers believed that the preferred mode of initial binding of the prochiral olefinic 
substrate to the catalyst determined the enantioselectivity, but in actual fact it is actually due 
to the difference in the  rates of subsequent reactions of the catalyst-substrate adducts with 
H2.48 
 
Figure 9: Bidentate ligands used for hydrogenation. 
The enantioselectivity in simple terms results in the selective addition of hydrogen to the least 
hindered enantiotopic face of the double bond and with the substrate presenting itself to the 
catalyst in the energetically minimised way. The generally agreed mechanism is that the 
rhodium undergoes oxidative addition to the prochiral bond in which coordination of the 
metal to an adjacent donor atom in the substrate (eg N or O) together with non-bonded 
interactions between the chiral ligands and substrate determines facial selectivity. Thereafter, 
reductive elimination with retention of configuration leads to the chiral product with 
regeneration of catalyst. Ilya et al. conducted experiments which showed consistency with the 
idea that enantioselection takes place through the reversible coordination of the double bond 
in octahedral dihydride complexes, which can happen only if the resulting chelate cycle is 
formed in the less hindered quadrant, Scheme 16.49 Some reaction examples are illustrated in 
Scheme 17.50 





Scheme 1649: Stereoselection in Rh-catalyzed asymmetric hydrogenation through chelation 
with dihydride complexes. 
 
Scheme 17: Examples of ruthenium and rhodium-based hydrogenations. 
 
1.3 Organocatalysis 
Chemical transformations that use organic catalysts such as those in enzymatic / bioorganic 
catalysis and as ligands in organometallic catalysis have been known over the past century 
but it was not until the late 1990s that the field of organocatalysis was made popular as one of 
the main branches of enantioselective synthesis.51 Organocatalysis is defined as the use of 
small organic molecules as metal-free catalysts.  The advantages of organocatalysts include 
their stability in air and water,  their ready availability in nature in both enantiomeric forms,  
and their relatively low cost  and  low toxicity,  which  presents  a  huge  direct  benefit  in  
the production of pharmaceutical intermediates when compared with (transition) metal 
catalysts, which invariably leave trace amounts of heavy metals in the products.52 
Organocatalysts  can  be synthesized or accessed from  naturally  occurring  chiral molecules, 
and are also amenable to solid- phase  synthesis  and  high-throughput  screening  techniques. 




Essentially, organocatalysts can be classified as either Lewis bases, Lewis acids, Brønsted 
bases or Brønsted acids, examples of which are shown in Figure 10. Some catalysts are 
bifunctional having both an acid and base functionality. The catalytic cycles of these 
organocatalysts is initiated by either supplying or removing electrons or protons from a 
substrate or transition state.53 
 
Figure 10: Different classifications of organocatalyst. 
 
1.3.1  Aminocatalysis 
Owing to the natural abundance of nitrogen-centred compounds, most organocatalysts are 
found in a class termed aminocatalysts. Upon reaction these catalysts transform the substrates 
either into activated nucleophiles (increased electron density at reaction centre) or 
electrophiles (decreased electron density at reaction centre) through enamine or iminium ion 
reaction intermediates respectively.54 These two forms are illustrated in Scheme 18 indicating 
the activated substrates. In such a way, the carbonyl group can manifest its well-known dual 
reactivity of electrophilic character at carbon and nucleophilic character at the α-position, 
depending on the reaction conditions.55 
 




Scheme 18: Equilibrium between iminium ion and enamine intermediates. 
(i) Iminium catalysis 
In iminium catalysis, the active species is an iminium ion which is formed by the reversible 
reaction of an amine catalyst with a carbonyl substrate. The higher reactivity of the iminium 
ion compared to the carbonyl species is used to assist reactions.56 From Scheme 18 above, 
there are two types of iminium ions that can be formed; simple iminium ions that arise from 
simple carbonyl substrates like those of Mannich reactions and extended iminium ions from 
α-β-unsaturated carbonyls in nucleophilic 1-4-additions.57  In 2000, the latter were exploited 
by David Macmillan and co-workers who established the first modern example of iminium 
catalysis in an enantioselective Diels–Alder reaction of α-β-unsaturated aldehydes and 
ketones with dienes using a chiral imidazolidinone catalyst, which is illustrated in Scheme 
19. Reaction of the α-β-unsaturated aldehyde with the enantiopure amine catalyst formed an 
activated iminium ion with a lowered LUMO (lowest unoccupied molecular orbital) energy, 
which reacted with cyclopentadiene to afford a Diels–Alder [4+2] cycloaddition in high ee  
(> 90%).58 Here, deprotonation of the iminium ion intermediate to an enamine cannot occur. 
 
 
Scheme 19: Diels-Alder cycloaddition of an α-β-unsaturated aldehyde. 
 
MacMillan and co-workers have also demonstrated the reaction capabilities of iminium 
catalysis for pyrrole 1,4-addition reactions with various α-β-unsaturated aldehydes as 
illustrated in Scheme 20.59 The pyrrole undergoes preferential 1,4-addition (Michael) at the 
prochiral terminus of the conjugated iminium ion as shown. Furthermore, the reaction 
achieves high enantioselectivity in that re-face (underneath) attack at the prochiral terminus is 
favoured in order to minimise steric interference between the nucleophile and the benzyl 
group on the auxiliary. Of crucial importance to the stereoselectivity is the intermediacy of 
the configuration shown as (E-), since a configurational mixture would result in a mixture of 




enantiomers. Deprotonation to regenerate aromaticity as well as hydrolysis of the enamine in 
order to turn over the catalyst generates the enantioenriched (R-) product as shown.  
 
Scheme 20: Friedel-Crafts alkylation of α-β-unsaturated aldehydes. 
 
(ii) Enamine catalysis 
By comparison, enamine catalysis involves the formation of an enamine intermediate that is 
generated through deprotonation of an iminium ion which then reacts with an electrophile or 
undergoes pericyclic reactions.60 Reaction of the enamine can proceed via two different 
routes depending on the nature of the electrophile. If the electrophile contains a double bond 
such as that in an aldehyde or imine nucleophilic addition occurs resulting in α-substitution of 
the original carbonyl substrate. Conversely, single bond-containing electrophiles undergo a 
substitution reaction (Stork alkylation reaction). A key feature of enamine catalysis is that it 
involves involvement of a relatively high-lying HOMO (highest occupied molecular orbital) 
of the enamine. In the early 1970s the Hajos–Parrish–Eder–Sauer–Wiechert reaction was the 
first example reported of an asymmetric intramolecular aldol reaction involving enamine 
catalysis (catalyzed by proline), Scheme 21.61 This is a desymmetrization reaction that 
differentiates between two enantiotopic carbonyl groups by virtue of hydrogen bonds formed 
between the carboxylic moiety of proline in an enamine and a carbonyl group in the transition 
state. 
 
Scheme 21: Intramolecular aldol reaction via enamine catalysis. 
 




The asymmetric Mannich reaction is another useful methodology for the formation of C-C 
bonds in chiral products containing nitrogen. It involves the reaction between an enolisable 
substrate and an imine leading to the formation of a β-aminocarbonyl product, a motif 
commonly found in both natural products and pharmaceuticals.62 In 2000, Benjamin List and 
co-workers described the first Mannich reaction catalysed by L-proline, which stimulated the 
rapid development of many other asymmetric organocatalytic Mannich reactions.63, 64 Later 
in 2006, Barbas and co-workers synthesized an amino acid catalyst that is a highly  
anti-diastereo- and enantioselective Mannich catalyst for reactions involving simple 
aldehydes with N-p-methoxyphenyl (PMP)-protected imines, as shown in Scheme 22.65  
 
Scheme 22: Anti-diastereoselective and enantioselective Mannich reaction. 
1.3.2 Phase-Transfer catalysis 
Asymmetric phase-transfer catalysis (PTC) has been recognized as an alternative to many 
homogeneous synthetic organic transformations because of its preparative advantages, which 
include simple reaction procedures, mild conditions, and relatively inexpensive and 
environmentally friendly reagents.66 Phase-Transfer catalysts are used to bring the reactant 
into contact with the substrate where each one has opposite solubilities in aqueous and 
organic media. This may occur by a reagent crossing over or via reaction at the media 
interface. Synthetically modified cinchona alkaloids (as ammonium salts) are typical chiral 
organocatalysts used in asymmetric PTC. In 1984 the Merck group reported the first efficient 
asymmetric PTC, in which methylation of a phenylindanone derivative was catalyzed by an 
N-alkylated (bridged nitrogen) cinchonidinium salt in high enantioselectivity.67 In 1989, 
O’Donnell and co-workers developed cinchona alkaloid-derived chiral quaternary ammonium 
salts for the asymmetric synthesis of amino acids using a Schiff-base substrate.68 Several 
generations of O-alkyl N-arylmethyl derivatives of the catalyst were developed, which led to 
highly enantioselective alkylation reactions of glycine imines for producing a range of  
α-amino acid derivatives, Scheme 23.69 





Scheme 23: Cinchona alkaloid-catalyzed phase-transfer reaction. 
 
1.3.3 Hydrogen-Bonding catalysis 
Hydrogen-bonding interaction is also a powerful tool for activating Lewis basic substrates via 
general acid catalysis. Much effort has been directed toward the development of new 
Brønsted acid catalysts, which has led to the discovery of several types of hydrogen-bonding 
donors such as ureas / thioureas, diols, and phosphoric acids, and these have become an 
important alternative to metal catalysts. Thioureas containing N-aryl groups bearing electron-
withdrawing substituents at the meta- and para-positions, have a significant accelerating 
effect due to their rigid conformation, which minimizes the entropic penalty upon 
complexation with carbonyl compounds, Figure 11.70  
 
Figure 11: Proposed hydrogen-bonding interaction of a thiourea catalyst. 
 
Similarly, Rawal and co-workes reported that TADDOLs could be used as weak Brønsted 
acid organocatalysts to achieve highly stereoselective hetero-Diels–Alder reactions via  
H-bonding between the Lewis basic carbonyl oxygen and the hydroxyl groups. Scheme 24 
shows the reaction of a heterodiene with benzaldehyde to afford a dihydropyrone as a single 
stereoisomer.71 






Scheme 24: Hetero-Diels-Alder reaction via hydrogen-bonding catalysis. 
 
1.4 Amination 
The introduction of nitrogen at the α-position of a carbonyl compound is a highly desirable 
transformation in synthesis, in which  asymmetric catalysis offers opportunities to produce 
optically active α-amino acids, α-amino aldehydes and α-amino alcohols.72 In 2002, Benjamin 
List and Karl Jørgenson simultaneously reported a simple and efficient method for the direct  
α-amination of unbranched aldehydes using diazodicarboxylates as a nitrogen source and 
proline as a catalyst.73, 74 The α-hydrazino aldehyde products were configurationally unstable 
in that racemization occurred due to the presence of an acidic α-H thus, the aldehyde group 
was  reduced in situ into α-amino alcohols using NaBH4, which resulted in a high yield  
(93-99%) and enantioselectivity (86-97%) of the α-hydrazino alcohols. These were 
subsequently cyclised under basic conditions, and their N-N bond reductively cleaved to 
afford chiral, non-racemic (R)-oxazolidinones, Scheme 25.75  
 
Scheme 25: L-Proline catalyzed α-amination of unbranched aldehydes. 
 
Jørgensen and co-workers also reported a proline-catalyzed enantioselective direct  
α-amination of ketones. The reaction of simple aliphatic ketones were found to be fairly 
regioselective, as the amination took place at the more highly substituted carbon atom, and 




the reaction proceeded with high enantioselectivities. In later reports quaternary stereogenic 
centres were generated at the α-position of branched aldehydes and ketones, Scheme 26.76 
  
 
Scheme 26: α-Amination of ketones. 
Barbas and co-workers extended the methodology by combining acetone, an aldehyde and 
dibenzyl azodicarboxylate, also using L-proline as the catalyst, in a one-pot synthesis to 
afford functionalized β-amino alcohols in high yields, with low diastereoselective control but 
good enantioselectivity (91-99%) of the anti-adducts, Scheme 27.77 
 
Scheme 27: Amination of β-amino alcohols. 
 
The choice of proline as the aminating catalysts has been based on its  bifunctional  
properties, involving  both  a  nucleophilic  secondary  amino  group that reacts as a Lewis 
base and  a carboxylic acid moiety functioning  as a Bronsted acid. This facilitates a highly 
pre-organized transition  state  during  reactions  involving  enamines  as intermediates,  
resulting  in  exceptionally  high enantioselectivities.78 In the transition state, the facial  
approach  of  the  diazodicarboxylate  is  directed  by  interaction  of  the  incoming  nitrogen 
atom with the proton of the carboxylic acid of the L-proline-promoted enamine  intermediate 
to  produce  the  R-enantiomer  (assisted  model).  The S-enantiomer can easily be formed 
using D-proline as the catalyst, although an alternative approach is to use Jorgensen's proline-
derived steric catalyst (α,α-diarylprolinol silyl ether) which produces high enantioselectivities 
in a steric model.  Here, the  observed stereochemistry  can  be  explained  by  considering  




that  steric  repulsion  between  the  catalyst side  chain  and  the  azodicarboxylate  ester 
directs  the  electrophile  anti  (steric model), Figure 12.79 
 
Figure 12: Enamine transition state models showing formation of the different enantiomers. 
Cinchona alkaloids and their derivatives are also organocatalysts that have found extensive 
application in asymmetric amination in which good enantioselectivities can be secured with 
quaternary centres. In 2012, Russo and co-workers described the α-amination of cyclic  
β-ketoesters and lactones with dibenzyl azodicarboxylate in the presence of natural cinchona 
alkaloids such as cinchonine and cinchonidine. Cyclic β-ketoesters easily afforded both 
enantiomers in high yields and good enantioselectivities, Scheme 28.80 
 
Scheme 28: α-Amination of β-ketoesters to form quaternary centres.






2.1 Scope  
In the previous chapter the concept of enantioselective α-amination in organocatalysis was 
introduced. In 2008, Kalch and co-workers developed an enantioselective synthesis of cyclic 
amino acids using the organocatalytic α-amination reaction of aldehydes functionalized with 
an acetal group, shown in Scheme 29.81  
 
 
Scheme 29: α-Amination of acetal functionalized aldehydes. 
In 2014, a co-worker in our research group reported the first one-pot enantioselective  
α-amination of acetals, which gave good yields (70-81%) and enantioselectivities (70-86%),  
as illustrated in Scheme 30.82  The reaction conditions comprised of an acetal, aqueous 
monochloroacetic acid as Brønsted acid (with catalytic trifluoroacetic acid), proline or its 
tetrazole derivative as organocatalyst, and DBAD as the diazodicarboxylate nitrogen source. 
Reaction is thought to proceed via the oxocarbenium ion to the enamine rather than via 




Scheme 30: α-Amination of an acetals. 
To widen the substrate scope, the α-amination of a δ-lactol was also conducted on the basis of 
it also being a masked carbonyl functionality (as a hemi-acetal). Using a low equivalent of 




acid (0.1 eq.) in the reported conditions shown in Scheme 36 gave excellent 
enantioselectivity as shown in Scheme 31. 
 
Scheme 31: α-Amination of a hemi-acetal. 
This interesting development led to the objective behind this project, which was to investigate 
whether these ideas could be extended to aminal systems. 
 
2.2 Aminals 
Hemiaminals are a functional group having an amino and a hydroxyl group bonded to the 
same carbon atom, and are derived from the aminal group, also known as an aminoacetal, 
which has two amino groups bonded to the same carbon atom. This group of functionalities 
appear in several natural and unnatural product structures as shown in Figure 13.  
 
Figure 13: Examples of compounds containing aminal and hemiaminal functionality. 
Hemiaminals are important intermediates in the preparation of azanucleosides with antiviral, 
antiprotozoan and anticancer properties.83 Hemiaminals have been mainly synthesized from 
the reduction of lactams rather than their aminal precursors. Sadovoy and co-workers 
reported the use of NaBH4 in methanol / dichloromethane (3 : 1) mixtures for reducing  
N-protected succinimides to the corresponding 5-hydroxypyrrolidin-2-ones, Scheme 32, 
which is more stable in the cyclic form.84  
 
Scheme 32: Reduction of succinimide to its hemiaminal. 




Piperno and co-workers used Schwartz reagent, Cp2Zr(H)Cl, to reduce β-, γ-, δ- and  
ε-lactams through hydrozirconation into lactamols, while other literatures report the use of 
DIBAL-H or LiEt3BH.85 They also indicated that reduction of N-carbamate protected lactams 
affords the lactamol and the tautomeric aldehyde product by ring opening, Scheme 33, 
reminding us that the hemiaminal is indeed a masked aldehyde. 
 
 
Scheme 33: Reduction of lactams. 
2.3 Aims and Objectives 
The aim of this thesis was to take advantage of this equilibrium tautomerism to functionalize 
the masked aldehyde by the enantioselective α-amination reaction. Cleavage of the N-N bond 
followed by deprotection and oxidation would then afford the useful target α-amino lactams 
(TM1 and TM2) as illustrated in Scheme 34. 
 
Scheme 34: α- Amination of hemiaminals. 
Scheme 35 below shows the mechanism of proline reacting with an aldehyde forming an 
enamine which then reacts with the diazo-electrophile to form an iminium ion. After 
hydrolysis and subsequent proton transfer the aminated aldehyde is formed releasing proline 
back into the system. 






Scheme 35: Proline-catalysed -amination mechanism. 
There are other methods that have been used to synthesize TM 1 and TM 2. Varala and  
co-workers86 used a NaNH2 / liq. NH3 methodology for cyclisation, Scheme 36, which starts 
the synthesis by converting L-glutamic acid 1 into its bis-dimethyl ester by refluxing with 
thionyl chloride in methanol. The amino group was then protected with di-tert-butyl 
dicarbonate (Boc)2O in a mixture of dioxane and water with a catalytic amount of  
4-dimethylaminopyridine (DMAP) to afford N-Boc-L-glutamic dimethyl ester 2. Treatment 
of 2 with Na / liq. NH3 in dry THF then led to imide formation, which was then  
Boc-deprotected with trifluoroacetic acid in DCM to afford α-amino imide 3 in homochiral 
form. 
 
Scheme 36: Synthesis by NaNH2/liq. NH3 methodology. 
Petrov and co-workers synthesized 2-pyrrolidinones with an amino group in 3 position.87 The 
synthesis, Scheme 37, begins with a hydrogenation / hydrogenolysis sequence in methanol 
using Raney-Nickel to cleave the N-N bond of the pyrazoline-3-carboxylic acid methyl ester 




1 followed by cyclocondensation of diamine intermediate 2 to afford 3-aminopyrrolidin-2-
one 3. Here a racemic mixture of 3 was obtained.  
 
Scheme 37: Synthesis by hydrogenation / hydrogenolysis. 
2.4 Application 
Target molecules 1 and 2 above can be used in the synthesis of biologically active 
compounds such as pomalidomide (Pomalyst®) illustrated in Scheme 38. This compound is a 
small molecule analogue of thalidomide developed by Celgene Corporation for the oral 
treatment of haematological and connective tissue diseases, and when used with low-dose 




Scheme 38: Synthesis of pomalidomide. 
 
The general synthesis of pomalidomide 3 is a one-step reaction between amine-substituted 
phthalic anhydride 1 and α-aminoglutarimide 2 in a medium of sodium acetate in acetic 
acid.89 It is administered as a racemate because it racemises in vivo. However, the importance 
of producing chiral, non-racemic compounds was discussed in Chapter one with thalidomide 
as an example. In this project the objective was to use enantioselective organocatalysis to 
produce chiral, non-racemic products derived from five- and six-membered cyclic 
hemiaminal starting materials with the carbonyl group inside (endo) or outside (exo) the ring. 





Results and Discussions 
3.1 Synthesis of hemiaminal type 1 
The first hemiaminal type 1 synthesised for amination studies was hemiaminal target 2 
(Scheme 39) containing an endocyclic carbonyl group, which was prepared from 
succinimide. The first step involved N-benzylating with benzyl bromide and potassium 
carbonate via a known procedure90 to afford N-benzyl succinimide 1. This reaction proceeded 
through an SN2 pathway, in which carbonate is basic enough to deprotonate the relatively 
acidic imide hydrogen. Following work-up and isolation via column chromatography, 
analysis of the 1H NMR spectrum of product 1 showed a new multiplet between  
7.36 - 7.14 ppm integrating for five aromatic protons as well as two benzylic protons as a 
singlet at 4.58 ppm. A singlet integrating for four equivalent protons was also observed as 
expected for the equivalent ring hydrogens (due to symmetry) at 2.61 ppm. Subsequent 
chemoselective reduction of 1 with sodium borohydride at low temperature afforded 
hemiaminal 2 in good yield (68%), Scheme 39.  
 
Scheme 39: Synthesis of hemiaminal 2. 
 
Of key importance in the reduction was the need to avoid subsequent reduction of the aminal 
2, which occurred  between 0 °C and room temperature to afford the ring-opened  
4-hydroxybutyramide 2a, Scheme 39. A mixture of methanol / dichloromethane (3 : 1) was 
used as solvent as suggested by the authors91 to avoid precipitation of the substrate that 
occurred in neat methanol at -40 °C. Analysis of the 1H NMR spectrum of product 2, Figure 
14, showed the four heterocyclic ring protons originally in the form of a singlet in compound 
1 to be much more complex, indicating that the protons were no longer equivalent. Overall, 
there was an upfield shift in line with the lower electron-withdrawing ability of the hydroxyl 




group in 2 compared to the carbonyl group in 1. Signals were complex in view of multiple 
couplings due to geminal and vicinal couplings in view of each methylene set being 
diastereotopic due to the newly introduced chiral centre (*). In addition, the two benzylic 
protons (H6) appeared as two distinct diastereotopic AB doublets at 4.76 ppm and 4.15 ppm 
because of the new chiral centre. A new signal integrating for one proton (H5) was observed 
at 5.02 ppm as a triplet due to coupling to the neighbouring two protons at H4 with an 
average J value of 5.3 Hz. 
 
Figure 14: 1H NMR spectrum of compound 2. 
Further reduction of the lactam carbonyl can be controlled as it enjoys greater resonance 
stabilization than the carbonyl groups of the imide due to a full donation of the nitrogen lone 
pair of electrons. This reduces the electrophilicity of the lactam carbonyl towards 
nucleophilic (hydride) attack compared to the case for the carbonyl groups of the imide, 
Figure 15.  
 
 
Figure 15: Resonance interpretation of the chemoselective reduction. 
The next and key step addressed the essential issue of this thesis, namely that of 
enantioselective α-amination involving the reaction introduced by Jorgensen and List in 
2002.  The mechanism of this elegant reaction has already been described in Chapter 2 (page 




29), in which an aldehyde transforms into its chiral enamine. Thus, the crucial issue here was 
whether the hemiaminal would open to the aldehyde in order to promote this. Alternatively, a 
mechanism via the N-acyliminium ion was thought possible, although this would need acid 
catalysis from the proline carboxyl group to be successful, which seemed unlikely. These 
ideas are depicted in Scheme 40.  
 
Scheme 44: Options for the enantioselective amination of 2. 
In the event a reaction was carried out between 2 (1.5 equivalents), diisopropyl 
azodicarboxylate (DIAD)  as limiting reagent and 50 mol% L-proline in acetonitrile at three 
different temperatures of 0 °C, room temperature (RT) and 30 °C. Reactions were followed 
by TLC, but after 24 hours no reaction had occurred based on the retention of both reactants 
without any other spots forming on the TLC plate. The high amount of catalyst was used just 
to check for reactivity.   
Based on this lack of reactivity, it was decided to resort to acid catalysis, which is not 
normally used for aldehyde amination, but does feature in a range of organo-aminocatalysis 
reactions.99 The selection of acids tested as trifluoroacetic acid, monochloroacetic acid and 
acetic acid (at 1.0 equivalent to the limiting reagent) was made based on the acetal  
α-amination reaction mentioned in Chapter 2. After 15 minutes TLC showed that a reaction 
had occurred by virtue of the presence of a new non-polar spot. NMR spectroscopic analysis 
following work-up and isolation using column chromatography, however, revealed that 
amination as hoped for had not occurred, but rather that an adduct of proline and  DIAD had 
formed without involvement of the substrate. 
 
At this stage it was rationalised that the two likely reasons for failure were the size of the ring 
and / or the position of the carbonyl group to facilitate the ring-opening. The influence of 
changing the size of the ring while keeping the protecting group constant was studied first, by 




switching to the six-membered aminal 4 derived from glutarimide 3. The reaction began with 
refluxing glutaric acid in neat acetyl chloride to form the anhydride, which following the 
removal of excess acetyl chloride on the vacuum pump then underwent a nucleophilic acyl 
substitution (SNAc) opening with benzylamine to the amide-acid. Ring closure of this 
intermediate was then achieved by a second treatment with acetyl chloride. The entire 
sequence could be successfully carried out in a one-pot sequence, Scheme 41. 
 
Scheme 41: Synthesis of glutarimide 3. 
The 1H NMR spectrum of glutarimide 3 confirmed its formation in which five aromatic 
protons were observed between 7.30 - 7.08 ppm, two benzylic protons as a singlet at  
4.85 ppm, a triplet at 2.55 ppm integrating for four protons (H3 and H5),  and a quintet for 
the H4 protons at 1.82 ppm in accordance with the reported literature values.92 Thereafter, 3 
was selectively reduced to 6-hydroxypiperidin-2-one 4 using sodium borohydride in a 
mixture (3 : 1) of methanol / dichloromethane as previously mentioned for 2, Scheme 42. 
Analysis of its 1H NMR spectrum, Figure 16, again showed complex signals for the ring 
protons between 1.66 - 2.44 ppm, a set of AB doublets for the diastereotopic benzylic protons 
at 5.01 ppm and 4.29 ppm respectively, and a deshielded triplet at 4.85 ppm for H6 due to 
coupling with the adjacent H5 vicinal protons (average J value of 2.7 Hz).93 
 
Scheme 42: Reduction to hemiaminal 4. 





Figure 16: 1H NMR spectrum of compound 4. 
Unfortunately, once again all attempts to α-aminate 4 were unsuccessful even using acid 
catalysis. The remote possibility that the lack of reactivity had something to do with the 
choice of benzyl as N-protecting group, led to protection using a para-methoxybenzyl (PMB) 
protecting group.94 This was achieved as before (Scheme 39) except using para-
methoxybenzyl chloride to afford 5 as a white solid in an excellent yield of 96%, Scheme 43. 
Analysis of its 1H NMR spectrum revealed an AB system in the aromatic region at 7.69 ppm 
and 6.72 ppm integrating for two protons each, which served as evidence of a  
1,4-disubstituted benzene ring, together with a methoxy singlet seen slightly downfield as 
expected at 3.70 ppm.  
 
Scheme 43: Synthesis of hemiaminal 6. 
 
As before, 5 was selectively reduced with sodium borohydride to afford 6 as a white solid 
with a corrected yield of 66% (at 60 % conversion). Figure 17 shows its 1H NMR spectrum 
which confirmed the formation of 6 based on the appearance of H6 as a doublet of triplets 
due to a large ax-ax coupling at 5.05 ppm as well as an OH proton at 5.94 ppm. Also, 
interestingly H7 now appears as a singlet. 





Figure 17: 1H NMR spectrum of compound 6. 
Amination reactions were again unsuccessful and so attention turned towards changing the 
protecting group to a more electron-withdrawing group in the hope of facilitating ring 
opening due to greater charge stabilization of the charge over a more delocalised system. For 
this purpose the carbamate protecting groups tert-butoxycarbonyl (Boc) and carboxybenzyl 
(CBz) groups were considered based on their use as standard protecting groups in peptide 
chemistry. The first one tried was Boc, which was introduced by reacting glutarimide with  
di-tert-butyl dicarbonate, (Boc)2O, and 4-dimethylaminopyridine (DMAP) in acetonitrile via 
a SNAc reaction. This afforded 7 in a moderate yield of 62% as an orange solid after work-up 
and isolation by column chromatography. The mechanism of acyl transfer is illustrated in 
Scheme 44 involving a sequence of SNAc reactions with intermediacy of a highly 
electrophilic N-Boc-pyridinium species as the key event.  
 
Scheme 44: Synthesis of imide 7. 




The structure of 7 was confirmed by 1H NMR spectroscopy in which two sets of multiplets 
were observed at 2.51 ppm (H4) and 1.90 ppm (H3 and H5) as well as a singlet integrating 
for nine protons at 1.44 ppm as evidence of t-butyl group introduction. Attempts to 
chemoselectively reduce 7 with sodium borohydride at -40 °C disappointingly resulted in 
over reduction to alcohol 8a, while carrying out the reaction at -78 °C or using lower 
equivalents also gave the same outcome. The 1H NMR spectrum of 8a is shown in Figure 18 
revealing a NH singlet at 7.82 ppm, two sets of triplets at 3.57 ppm (H6) and 2.68 ppm (H3) 
integrating for two protons each and a broad OH singlet at 2.39 ppm. Formation of 8a 
indicated the formation of hemiaminal 8 as an intermediate, which presumably opened up 
readily into the aldehyde, which in turn resulted in over-reduction, Scheme 45. However, 
these results suggested that the substrate structure was improving in terms of our desired aim. 
 
Scheme 45: Reduction of compound 7. 
 
Figure 18: 1H NMR spectrum of compound 8a. 
 




To this end, studies resorted back to the five-membered ring case, in which the anion of 
succinimide was reacted with benzyl chloroformate (CBzCl) to form compound 9 as a 
colourless solid, Scheme 46, in modest yield after work-up and column chromatography.  
 
Scheme 46: Synthesis of CBz-protected succinimide 9. 
The structure of compound 9 was confirmed by analysis of the 1H NMR spectrum, which 
showed a downfield singlet at 5.31 ppm for the newly introduced benzyl methylene group. 
Furthermore, the 13C NMR spectrum confirmed the presence of a third carbonyl resonance at 
152.3 ppm corresponding to C6 together with the existing carbonyl carbons (C2 and C5) at 
176.6 ppm and infrared (IR) analysis further confirmed 9 by the presence of three C=O peaks 
at 1785 cm-1, 1779 cm-1 and 1798 cm-1. Reduction to hemiaminal 10 using sodium 
borohydride in methanol / dichloromethane at -40 °C surprisingly did not result in an  
over-reduction even though it was thought that the five-membered ring was more likely to 
open up. The reaction gave a very low yield of 10 (< 10%) with full conversion over an 
extended period of time and so the reaction was conducted at -78 °C, which gave a 1 : 2 
mixture of compound 10 and methyl ester 10a in near quantitative yield overall following 
column chromatography. The formation of ring-opened compound 10a may be explained by 
assuming that methanol, probably in the form of methoxide or a methoxyborate species was 
able to attack the relatively electrophilic imide endo-carbonyl group, which has an enhanced 
electrophilicity due to the extra CBz electron-withdrawing carbonyl group, Scheme 47.  
 
Scheme 47: Reduction of CBz-protected succinimide 9. 




The structure of 10a was supported by its 1H NMR spectrum shown in Figure 19, which 
revealed a deshielded methoxy singlet at 3.58 ppm integrating for three protons, a singlet at 
7.57 ppm (NH) and two sets of triplets at 2.99 ppm and 2.56 ppm for the desymmetrized 
methylene groups. The absence of chirality (compared to the hemiaminal) ensured a 
relatively simple spectrum, while the use of lithium aluminium hydride in THF at -78 °C 
gave no improvement (20% of 10), presumably as a result of its higher reactivity. 
 
Figure 19: 1H NMR spectrum of compound 10a. 
Formation of hemiaminal 10 was confirmed by a doublet at 5.68 ppm in the 1H NMR 
spectrum integrating for one proton for H5, a doublet indicating in this case that one of the 
(vicinal) dihedral angles was close to 0 degrees according to the Karplus equation. 
Interestingly the doublet appeared twice (5.77) – see inset in Figure 20 - indicating the 
presence of N-CO(exo) rotamers,  in a ratio of about 4 : 1 by NMR. This was confirmed by the 
doubling of signals observed in the 13C NMR spectrum of 10 at 86.3 ppm and 86.6 ppm for 
C-5. The two rotamer structures are shown in Figure 21. 





Figure 20: 1H NMR spectrum of compound 10. 
 
Figure 21: N-CO(exo) rotamers. 
Enantioselective α-amination of 10 was attempted using DIAD, 50 mol% L-proline in 
acetonitrile at 0 °C and at room temperature and at 30 °C and once again this reaction was 
unsuccessful. This significant set of results was interpreted as indicative that the reaction was 
not going to work with an endocyclic carbonyl group, and so the focus of attention now 
switched to hemiaminals of type 2 containing no endocyclic carbonyl group. 
3.2 Synthesis of hemiaminal type 2 
These hemiaminals contained the stabilizing carbonyl group exo to the ring and could be 
accessed from the corresponding lactam. Thus, reactions were conducted for the  
five-membered ring, and commercially available 2-pyrrolidinone was acylated with benzyl 
chloroformate via its anion formed using sodium hydride. In such a way N-protected lactam 
11 could be produced in modest yield (60%) following a conventional work-up and column 
chromatography, Scheme 48. Analysis of its 1H NMR spectrum confirmed the acylation with 
the introduction of benzyl signals. In this case, 11 was obtained as a single rotamer based on 
a single set of resonances in both the 1H and 13C NMR spectra, depicted in Scheme 48 as the 
s-trans configuration (red arrow) in order to minimise carbonyl / carbonyl repulsion. 





Scheme 48: Synthesis of CBz protected 2-pyrrolidinone 11. 
Compound 11 was then selectively reduced to 2-hydroxypyrrolidine 12 using sodium 
borohydride in a methanol / dichloromethane mixture under conditions described for the 
imide cases before, Scheme 49. Following work-up and chromatography aminal 12 was 
obtained in an excellent yield of 91%.  It’s 1H NMR spectrum shown in Figure 22 revealed a 
broad H2 multiplet centred at 5.51 ppm, although the presence of two signals again suggested 
rotamers with a minor H2 peak at 5.49 ppm, which was supported by the doubling of signals 
in the 13C NMR spectrum at 81.2 ppm and 80.9 ppm for C2 as shown in Figure 23.  
Similarly, the introduction of a chiral centre at C2 resulted in the H5 protons appearing as 
diastereotopic multiplets with different chemical shifts (in 11 they were a triplet due to being 
enantiotopic).  
 
Scheme 49: Reduction to exocyclic aminal 11. 





Figure 22: 1H NMR spectrum of compound 12. 
 
Figure 23: 13C NMR spectrum of compound 12. 
Enantioselective α-amination was attempted again using L-proline (50 mol%) and 1.0 
equivalent of DIAD in acetonitrile at room temperature for 3 days without an acid catalyst to 
obtain a more polar product 13 in an excellent yield of 92% as a yellow oil following a  
work-up with aqueous ammonium chloride, and isolation using column chromatography. 




Reactions were initially conducted using 50 mol% L-proline, but pleasingly, decreasing the 
catalyst load to10 mol% gave similar results, Scheme 50.  
 
Scheme 50: α-Amination of compound 12. 
The reason for the success this time is probably something to do with the hydrogen-bonding 
stabilisation in ring opening to the aldehyde that is offered by having the carbonyl group exo. 
Such stabilisation is denied in the endo-case. Figure 24 summarises: 
 
Figure 24: hydrogen-bonding stabilisation in ring opening. 
An unambiguous structural assignment for 13 proved to be challenging in view of the various 
stereogenic elements possible in the product. Upon α-amination a further chiral centre is 
formed creating the possibility of diastereomers, and indeed 13 did appear on TLC as two 
closely-running spots. Other stereogenic elements for consideration, though, were the axial 
rotation axes of both the N-CBz moiety – this had shown to be operative in starting material 
12 – as well as the hydrazide carbamate around the tertiary nitrogen centre. These 
possibilities are depicted individually in Figure 25. 





Figure 25: Illustration of stereogenic elements in 13. 
Needless to say this posed a difficult challenge. The 1H NMR spectrum of 13 showed that 
amination had taken place by virtue of the appearance of high-field isopropyl resonances 
observed as a number of non-equivalent doublets integrating for 12H - see inlet in Figure 26 - 
against the 5H for the CBz phenyl group, as well as a deshielded signal for H3 (4.52 ppm) 
relative to its chemical shift in the starting material 12 (1.80 ppm). Signals appeared as broad 
and relatively unresolved indicating a complex mixture of conformers to be present. 
Regarding isomers, an approximately 2 : 1 mixture of compounds could be seen, based on the 
following resonances:  the appearance of a singlet integrating for one NH proton observed at 
6.67 ppm together with its minor signal at 6.51 ppm and an H3 major resonance at 4.52 ppm 
as a broad singlet with its minor singlet at 4.19 ppm. The 13C NMR spectrum, Figure 27, of 
13 revealed two distinct carbonyl resonances at 156.9 ppm for C6 and C4’ and C3’ 
overlapping at 155.4 ppm, showing that the isomers did not manifest differences in that 
region. In addition, there was doubling of signals in the isopropyl region at 22.1 ppm and 
22.0 ppm, of C3 at 64.0 ppm and 60.5 ppm and of C4 at 34.0 ppm and 33.0 ppm to 
corroborate the notion of a 2 : 1 mix. Analysis of the infrared spectrum of 13 indicated a 
broad band of overlapping carbonyl stretches at 1684 cm-1, a broad band at 3291 cm-1 
corresponding to the O-H stretch and a shoulder band at 3384 cm-1 corresponding to the N-H 
stretch. High resolution mass spectroscopy (HRMS) using an electrospray ionization (ESI) 
mode found 446.1888 for C20H29N3NaO7 [M+Na]+  which agreed well enough with the 




calculated mass of 446.1903, lending further confidence to the assignment of structure 13 as 
shown. 
 
Figure 26: 1H NMR spectrum of compound 13. 
 
 
Figure 27: 13C NMR spectrum of compound 13. 




Based on the data, it was attractive to suggest that the 2 : 1 ratio translates to a diastereomer 
level, and indeed this was what was observed later in high pressure liquid chromatography 
(HPLC) studies. Optimization studies of the reaction to obtain the greatest yield were carried 
out with respect to temperature and the addition of an acid catalyst, and the results are shown 
in Table 2, which showed that the best conditions for optimizing the yield were to run the 
reaction at room temperature (RT) for 3 days in the absence of acid, (Entry 2). The 
temperature of the optimized reaction as RT agreed with that of the original amination by List 
and Jorgensen, the much longer reaction time presumably reflected the issue of ring opening 
to the aldehyde. These reactions were stopped once 100% conversion of DIAD (as limiting 
reagent) had been achieved. 
Table 2: Enantioselective α-amination of compound 12. 
Entry Temp. AcOH eq. Time Yield % 
1 0 °C - 4 d 62 
2 RT - 3 d 92 
3 RT 1 3 d 48 
Since cleavage of the N-N bond required hydrogenation, which would cleave the CBz 
protecting group, it was decided to repeat the sequence with a Boc protecting group. To this 
end, commercially available 2-pyrrolidinone was Boc-protected using (Boc)2O and DMAP in 
acetonitrile via a SNAc reaction affording 14 in an excellent yield of 95% as a yellow oil after 
column chromatography, Scheme 51.95 Analysis of its 1H NMR spectrum confirmed its 
formation based on the appearance of a singlet observed at 1.45 ppm integrating for nine 
protons for the Boc t-butyl group, while the 13C NMR spectrum revealed two carbonyl 
signals only at 173.8 ppm and 149.8 ppm, as with 11 indicting the lack of rotamers.  
 
Scheme 51: Synthesis of Boc protected 2-pyrrolidinone 14. 
As before, compound 14 was then selectively reduced to 2-hydroxypyrrolidine 15 using 
sodium borohydride in a methanol / dichloromethane mixture at -40 °C, Scheme 52. 




Following work-up and chromatography hemiaminal 15 was obtained in an excellent yield of 
92% as a colourless oil.96 Analysis of the 1H NMR spectrum shown in Figure 28 confirmed 
formation of 15 with an approximately 2 : 1 mixture of N-CO rotamers with evidence of  a 
major H2 peak at 5.40 ppm was seen together with a minor peak at 5.38 ppm. Again, the 
presence of two closely separated signals for H2 suggested rotamers.  Furthermore, the H5 
protons now appeared as diastereotopic multiplets at 3.40 ppm and 3.21 ppm due to the 
newly introduced chiral centre at C2.  
 
Scheme 52: Reduction to exocyclic aminal 15. 
 
 
Figure 28: 1H NMR spectrum of compound 15. 
Enantioselective α-amination of 15 was successful using the optimized results (Table 2, Entry 
2) obtained for compound 13 and in which 10 mol% of L-proline was used with DBAD, 
which allowed for UV detection of the product, in acetonitrile at room temperature. The 
reaction took 3 days to reach completion which was in accord with that of entry 2 in Table 2. 
Aminated hemiaminal 16 was produced in an excellent yield of 90% as a yellow oil after 




work-up with aqueous ammonium chloride and isolation via column chromatography, 
Scheme 53. 
 
Scheme 53: α-Amination of hemiaminal 15. 
The 1H NMR spectrum of 16, Figure 29, showed that amination had taken place based on the 
appearance of phenyl signals integrating for ten protons as well as H3 shifting downfield 
(4.56 ppm) from its position in 15 (1.85 ppm). Moreover, once again the broad lines 
suggested interplay between several rotameric forms, and based on a major NH signal at  
6.75 ppm and a minor one at 6.66 ppm as well as H3 appearing at 4.56 ppm and 4.02 ppm, a 
ratio of 2 : 1 for isomers was calculated as before. Likewise, the 13C NMR spectrum of 16, 
Figure 30, indicated the presence of three carbonyl groups with signals at 156.1 ppm (C6), 
155.6 ppm (C3’) and 154.9 ppm (C4’), while the doubling of signals at 80.7 ppm and 79.8 
ppm (C2) as well as at 44.6 ppm and 43.0 ppm (C5), supported the 2 : 1 mix. Analysis of the 
infrared spectrum of 16 indicated a broad band of overlapping carbonyl stretches at  
1696 cm-1, a broad band at 3185 cm-1 corresponding to the O-H stretch and a shoulder band at 
3300 cm-1 corresponding to the N-H stretch. To further confirm the formation of 16, HRMS 
using an ESI mode was conducted and found 508.2066 for C25H31N3NaO7 [M+Na]+ , which 
agreed well enough with the calculated mass of 508.2060. 





Figure 29: 1H NMR spectrum of compound 16. 
 
 
Figure 30: 13C NMR spectrum of compound 16. 
Finally, chiral HPLC was used to determine the number of individual peaks that could be 
identified. Enantiomeric excess (ee) measurements were carried out by HPLC using a 
Chiralpak AD column with a flow rate of 1mL / min at 254 nm and a mobile phase of  




2-propanol / hexane (1 : 9). The reaction was first repeated using DL-proline (racemic) in 
order to identify the various isomers. Analysis of the HPLC spectrum from the reaction, 
Figure 31, revealed four peaks as two sets of large(er) and small(er). The integration of the 
large to small in each pair agreed reasonably well with the NMR integration of a 2:1 mix of 
isomers suggesting that the NMR ratio corresponded to the large / small ratio of the HPLC. In 
turn this suggested that this ratio reflected the ratio of diastereomers. Conversely, the large / 
large or small / small ratio indicated the percentage of enantiomers, which within 
experimental error was 50 : 50 as expected. Peaks are labelled as follows:  
Enantiomers of diastereomer 1 (E1D1; E2D1) 
Enantiomers of diasteromer 2 (E1D2; E2D2) 
 
Figure 31: HPLC of racemic 16. 
Even though an excellent yield of 90% of the product was obtained, it was necessary to 
perform a study on the influence of reaction parameters on enantioselectivity. These were 
conducted with respect to temperature, solvent, catalyst and reagent respectively and once 
again reactions were monitored by the consumption of DBAD as a limiting reagent. Table 3 







E1D1          E2D1 
E1D2 E2D2 




Table 3: Temperature and acid additive studies. 























































































































The results showed that RT or above was needed to get a high yield within three days (as an 
acceptable limit) in which the highest enantioselectivity (entry 4) was at RT without 
additional acid (AcOH). The trace corresponding to entry 4 is shown in Figure 32 revealing a 
diastereomeric ratio of about 3 : 1 based on the large / small ratios and an enantioselectivity 
of 85% (84%) based on the large / large (93:7) and small / small (92 : 8) ones. The 
diastereoselectivity fluctuated and was temperature dependent presumably because of the 
possibility of ring opening and closure (epimerisation) at the C2 hemiaminal centre. The 
structure of the major isomer was not ascertained because later the C2 centre would be 
removed by oxidation. 
 
Figure 32: HPLC trace of Table 3 entry 4. 
Although reactions conducted in acetonitrile seemed to give good results, a solvent study to 
confirm this was carried out, Table 4. A selection of relatively ‘green’ solvents was chosen 








from a list published by the American Chemical Society Pharmaceutical Roundtable.97 
Reactions were conducted under the conditions from Entry 4 in Table 3 (see Scheme 53) with 
dry solvents and were left to go to 100% consumption of the DBAD, in which acetonitrile 
(Table 4, Entry 1) was confirmed as the best solvent as it gave the highest ee and yield in the 
shortest time. By comparison, ethanol gave no yield as this medium seemed to decompose the 
DBAD reagent (starting material remained intact while DBAD disappeared with the 
appearance of many spots). 
Table 4: Solvent studies using conditions from Scheme 57. 





































4 EtOAc 4,5 d 68 87 (13) 74 (76) 
 
Similarly, catalyst studies were then conducted at room temperature in acetonitrile. The 
catalysts chosen were; a. L-Proline, b.  (S)-(–)-5-(2-Pyrrolidinyl)-1H-tetrazole, c. (2R,5R)-2-
tert-Butyl-3-methyl-5-phenylmethyl-4-imidazolidinone and d. diphenylprolinol silyl ether. 
Although tetrazole (b) has proved to be a remarkable catalyst for many published reactions 
and gave an increase of ee in the acetal amination compared to that from proline, in this study 
only L-proline worked, indicating the importance of having the free carboxyl group, 













Table 5: Catalyst studies. 
Entry Catalyst time Yield (%) dr ee 
1 a 3 d 93 86 (14) 82 (83) 
2 b 5 d 0 - - 
3 c 6 d 0 - - 
4 d 6 d 0 - - 
 
 
Lastly was the reagent study of DBAD vs DIAD (diisopropyl azodicarboxylate) and DTBAD 
(di-tert-butyl azodicarboxylate) to afford products 16, 17 and 18 respectively. The formation 
of the DIAD product is described below, Scheme 54.  
 
Scheme 54: Formation of aminated hemiaminal 17. 
As with 16, the 1H NMR spectrum of 17, Figure 33, showed that amination using DIAD  
(1.0 eq.) and L-Proline (10 mol%) at room temperature in acetonitrile had taken place, and 17 
was obtained in a yield of 80% as a yellow oil following a work-up with aqueous ammonium 
chloride, and isolation using column chromatography. Proof of structure was based on the 
appearance of isopropyl group signals integrating for twelve protons at 1.20 ppm as a series 
of doublets. Also, H3 again shifted downfield (4.54 ppm) from its position in 15 (1.85 ppm). 
Furthermore, an interplay between several isomeric forms was again observed as with 16 
based on a major NH signal at 6.56 ppm and a minor one at 6.49 ppm, as well as a minor H3 
signal appearing at 4.08 ppm, which allowed an approximate ratio of 2 : 1 for isomers to be 
calculated. Likewise, the 13C NMR spectrum of 17 indicated the presence of three carbonyl 




groups with signals at 156.8 ppm (C6), 156.0 ppm (C3’) and 155.4 ppm (C4’), while the 
doubling of signals at 80.6 ppm and 79.2 ppm (C2) as well as at 44.7 ppm and 43.2 ppm 
(C5), supported the 2:1 mix. Analysis of the infrared spectrum of 17 indicated a broad band 
of overlapping carbonyl stretches at 1680 cm-1, a broad band at 3290 cm-1 corresponding to 
the O-H stretch and a shoulder band at 3380 cm-1 corresponding to the N-H stretch. To 
further confirm the formation of 17, HRMS was conducted and found 412.2054 for 
C17H31N3NaO7 [M+Na]+  which agreed well enough with the calculated mass of 412.2060. 
  
Figure 33: 1H NMR spectrum of compound 17. 
Owing to the non-UV activity of the DIAD and DTBAD products 17 and 18 oxidation to the 
corresponding lactams was necessary. Various oxidants were tried out: SWERN, Dess-Martin 
periodinane, pyridinium dichlorochromate and pyridinium chlorochromate (PCC) – and of 
these only PCC was successful.98 Scheme 55 indicates a general equation for the reaction 
together with a mechanism involving oxidation of a chromate ester with reduction at Cr.  The 
products from PCC oxidation were isolated via filtration through Celite® and chromatography 
to afford oils 16a, 17a and 18a in all three cases with yields of 68%, 67% and 66% for 
DBAD, DIAD and DTBAD respectively. A mechanism for the oxidation of hemiaminal 16 
(R containing a UV-active benzyl groups), is described below.  
H3 





Scheme 55: Oxidation of hemiaminal 16. 
The 1H NMR spectrum of 16a, Figure 34, once again revealed broad signals but did suggest 
that oxidation had taken place based on the disappearance of the H2 proton. In addition, the 
spectrum indicated one set of signals for the NH hydrogen at 6.75 ppm and H3 at 5.09 ppm 
overlapping with the benzylic protons H5’. The spectral data indicated that our interpretation 
of the 2 : 1 ratio (or thereabouts) in 16 being due to diastereomers (based on the HPLC data) 
was indeed correct. Also, only one spot was observed on TLC. The H3 proton shifted 
downfield to 5.09 ppm from 4.56 ppm due to the presence of the vicinal withdrawing 
carbonyl group. The 13C NMR spectrum of 16a, Figure 35, further proved the formation of 
16a by the appearance of a new carbonyl signal at 169.8 ppm in addition to the existing three 
carbonyl groups, and a single signal of H3 signals at 71.4 ppm. Analysis of the infrared 
spectrum of 16a indicated a broad band of four carbonyl stretches at 1713 cm-1 (two C=O 
stretches overlapping), 1787 cm-1 and 1798 cm-1, and a broad band at 3377 cm-1 
corresponding to the N-H stretch – see overlap in Figure 36. Additional confirmation was 
conducted using HRMS that found 506.1904 for C25H29N3NaO7 [M+Na]+,  which agreed well 
enough with the calculated mass of 506.1903. 





Figure 34: 1H NMR spectrum of compound 16a. 
 
 
Figure 35: 13C NMR spectrum of compound 16a. 





Figure 36: IR comparison of 16 (top) and 16a (bottom). 
We left the final word to chiral HPLC analysis. Pleasingly, only two peaks were observed, 
and based on the trace of the racemic product obtained from using DL-Proline, which showed 
two separated peaks for the enantiomers in a 1:1 ratio, an enantioselectivity of 84% was 
calculated (92:8), which did not change from an ee average of 84% in 16. This evidence 
demonstrated that indeed no racemization at the α-aminated centre via enolization had taken 
place by introducing a carbonyl group next to it, Figure 37. 
 
Figure 37: HPLC spectrum of 16a. 
Results of the amination reagent study are shown in Table 6 and these were calculated on the 
basis of 100% conversion of the amination reagent as before followed by oxidation with 
PCC, Scheme 56. The results revealed DBAD to be the best reagent with respect to yield and 
enantioselectivity. It was also observed that the reaction time increased with an increase in 


































































































































































bulkiness of the carbamate ester groups. Reaction with DTBAD formed many spots, creating 
isolation difficulty, which resulted in a low yield of product.  
 
Scheme 56: Oxidation of hemiaminals using PCC. 
Table 6: Reagent studies of the oxidized products. 
Cpd No electrophile Time Yielda (%) Yieldb (%) eeb (%) 
16 DBAD 3 d 90 68 85 
17 DIAD 6 d 80 67 80 
18 DTBAD 4 d 46 66 68 
a. Calculated after amination; b. Calculated after oxidation. 
The next step in the methodology development was to cleave the hydrazide N-N bond to 
afford the α-amino lactam as a useful synthesis intermediate.  
3.3 N-N bond cleavage 
Various methods have been reported for this conversion including: samarium diiodide,99 
lithium / liquid ammonia,100 hydrogenolysis with Palladium-on-carbon101 or Raney Nickel,102 
Zinc in acetone / acetic acid, and finally NaNO2 in an acetic acid / hydrochloric acid mixture. 
In the event lactam 16a was subjected to hydrogenolysis using palladium on carbon (2.0 eq.) 
in dry methanol at room temperature to remove the benzyl groups to afford hydrazine 19, 
followed by the addition of Raney Nickel to give 20, Scheme 57. 
 





Scheme 57: Hydrogenolysis of lactam using palladium. 
Surprisingly, the reaction to produce 19 did not work, giving inconclusive results (multiple 
spots and unassignable NMR spectra). Moreover, attempts to run the reaction at lower 
palladium equivalents (0.5 eq.), at higher temperatures, in different solvents or under pressure 
using a hydrogenator were unsuccessful. As such the conditions were changed to using Raney 
Nickel (2 eq.) in methanol and acetic acid at atmospheric pressure directly, which would 
hopefully afford amine 20, Scheme 58.  
 
Scheme 58: Atmospheric pressure hydrogenolysis of lactam using Raney Nickel. 
Yet again the reaction was unsuccessful with no reaction occurring and the starting material 
recovered.  At this stage it was decided to attempt N-N cleavage prior to hemiaminal 
oxidation. Owing to the sensitivity of the hydroxyl group to acid medium the reactions were 
conducted in the absence of acetic acid. Hydrogenolysis using the protocol in Scheme 57 
resulted in deamination back to 15 according to 1H NMR analysis and so it was decided to 
proceed directly with Raney Nickel at 8 equivalents, which resulted in a 20% conversion of 
16 to a more polar non-UV active spot on TLC which suggested the formation of an amine 21 
based on TLC staining, Scheme 59. Increasing the catalyst load to 64 equivalents gave 100% 
conversion after 24 hours. The results suggested that coordination of the hydroxyl to the 
nickel metal through hydrogen bonding facilitated the reaction. Conducting reactions under 
pressure at 2 bar, 2.5 bar and 4 bar gave no improvement in the amount of catalyst that 
needed to be used. 





Scheme 59: Atmospheric pressure hydrogenation of hemiaminal 16. 
Owing to the polarity of the product and thus the difficulty to isolate the α-amino 
hemiaminal, the reaction was filtered over Celite® and the crude product reacted with 
(Boc)2O in THF at room temperature to afford compound 20 in a yield of 65% over the two 
steps as a colourless oil, Scheme 60.  
 
Scheme 60: Formation of α-amino protected hemiaminal 22. 
Figure 38 shows the 1H NMR spectrum of 22 that confirmed N-N cleavage by the 
disappearance of the phenyl signals as well as the benzyl methylene groups. In addition, two 
Boc singlets at 1.38 ppm and 1.41 ppm were observed integrating for 18H (H8 and H4’). The 
presence of diastereomers was supported by the presence of extra peaks at 5.11 ppm. The  
13C NMR spectrum further confirmed the formation 22 as two carbonyl signals were 
observed at 155.1 ppm (C-2’) and 155.0 ppm (C-6) instead of three as seen in 16. Analysis of 
the infrared spectrum of 22 indicated a broad band of two overlapping carbonyl stretches at 
1700 cm-1 and 1695 cm-1 for the two carbamate carbonyl groups, a broad O-H band at 3290 
cm-1 and a shoulder band at 3387 cm-1 corresponding to the N-H stretch. Additional 
confirmation was conducted using HRMS that found 302.1743 for C14H26N2NaO5 [M+Na]+  
which agreed well enough with the calculated mass of 302.1740. This evidence was sufficient 
to confirm that 21 was indeed afforded as an intermediate product. 





Figure 38: 1H NMR spectrum of 22. 
Oxidation of 22 was accomplished using PCC in dry DCM at room temperature to afford 23 
in 65% yield as an oil after filtration through Celite® and column chromatography, Scheme 
61. 
 
Scheme 61: Oxidation of 22. 
Figure 39 depicts the 1H NMR spectrum which supports the formations of compound 23. The 
disappearance of H2 and the appearance of a third carbonyl signal at 171.6 ppm in the  
13C NMR spectrum provided significant diagnostic peaks.  Analysis of the infrared spectrum 
of 23 indicated a broad band of two overlapping carbonyl stretches at 1725 cm-1 and a band at 
1698 cm-1, as well as a broad band at 3389 cm-1 corresponding to the N-H stretch. Further 
confirmation was obtained by HRMS that found 323.1586 for C14H24N2NaO5 [M+Na]+, 
which agreed well enough with the calculated mass of 323.1583. Determination of the 
enantioselectivity by chiral HPLC revealed an ee of 78% (89:11), Figure 40, which had 




reduced from an ee average of 84% in 16 indicating that a small amount of racemisation had 
occurred. 
 
Figure 39: 1H NMR spectrum of 23. 
 
 
Figure 40: HPLC spectrum of 23. 
Further N-N cleavage studies were conducted on aminal 17 in which cleavage also required 
64 equivalents of Raney Nickel in methanol at 80 °C under reflux, Scheme 62. Moreover, the 
TLC profile obtained was different to that in Scheme 59 showing a spot which did not 
corroborate to amine formation. Upon filtration through celite® and isolation by 
chromatography, the desired compound 24 was obtained in 53% yield as a colourless oil, 
Scheme 62. 





Scheme 62: Atmospheric pressure hydrogenation of 17. 
Analysis of the 1H NMR spectrum, Figure 41, supported the formation of 24.  Although the 
spectrum profile was similar to that of compound 17, proton integration of the isopropyl 
group signal was halved in 24. Further confirmation was supported by the appearance of only 
two carbonyl signals in the 13C NMR spectrum at 156.5 ppm (C6) and 155.2 ppm (C2’). 
Analysis of the infrared spectrum of 24 indicated a broad band of two carbonyl stretches at 
1739 cm-1 and 1694 cm-1, a broad band at 3292 cm-1 corresponding to the O-H stretch and a 
shoulder band at 3368 cm-1 corresponding to the N-H stretch. Additional confirmation was 
obtained using HRMS which found 311.1584 for C13H24N2NaO5 [M+Na]+ which agreed well 
enough with the calculated mass of 311.1583. 
 
Figure 41: 1H NMR spectrum of 24.  
Finally, 24 was oxidized using PCC in dry DCM at room temperature to afford 25 as a 
colourless oil in 78% yield after filtration through Celite® and chromatography, Scheme 63. 





Scheme 63: Oxidation of 24. 
Analysis of the NMR spectra, Figure 42, showed the disappearance of H2 in the 1H NMR 
spectrum and the appearance of a third carbonyl signal at 171.6 ppm in the 13C NMR 
spectrum lending sufficient support evidence for the structure of 25 with the product obtained 
as a single diastereomer. Analysis of the infrared spectrum of 25 indicated a broad band of 
three carbonyl stretches at 1741 cm-1, 1725 cm-1 and 1695 cm-1 and a broad band at 3362 cm-1 
corresponding to the N-H stretch. Further confirmation was obtained by HRMS that found 
309.1429 for C13H22N2NaO5 [M+Na]+ which agreed well enough with the calculated mass of 
309.1427. Pleasingly, the ee by chiral HPLC was determined to be 86% (93:7), Figure 43.  
 
Figure 42: 1H NMR spectrum of 25.  





Figure 43: HPLC spectrum of 25. 
 
Since cleavage of the hemiaminal hydrazide 16 using Raney Nickel required a large excess of 
the catalyst and was hardly ‘green’ we sought for a milder, greener, and more importantly, 
safer method. One such method involved a novel in situ elimination reaction (E1cB) 
developed by Phillip Magnus and co-workers, which led to a further modification developed 
in our laboratory, which will be discussed in the next chapter. In conclusion, successful 
enantioselective -amination of a five-membered hemiaminal containing an exo- carbamate 
N-protecting group has been achieved. Cleavage with Raney Nickel followed by hydroxyl 
group oxidation afforded the N-protected-3-amino-2-pyrrolidinone in high ee. This new 
methodology opens up the way for enantioselectively -aminating lactams of different ring 
sizes. Interestingly, the equivalent N-protected 5-hydroxy-2-pyrrolidinone variant  
containing an endo-carbonyl group did not aminate under any conditions, probably  
due to a lack of hydrogen-bonding stabilisation in the ring opening step to generate  
the aldehyde for enamine formation and amination ultimately.





N-N cleavage via E1cB 
4.1 E1cB N-N cleavage introduction 
The conventional cleavage methods mentioned in Chapter 3 (section 3.3) are conducted 
under harsh conditions, and cause chemoselective problems with substrates containing 
hydrogen-responsive functionalities (eg. benzyl ethers or alkenes), thus limiting the substrate 
scope. In 2009, Magnus developed a method103 which made use of an E1cB mechanism 
(unimolecular elimination via the conjugate base) for reductive cleavage of the N-N bond of 
mono-N-alkylated hydrazine dicarboxylates to form carbamates.  The reaction occurs under 
mild basic conditions and proceeds by first deprotonation to form a carbanion followed by the 
loss of the leaving group. This type of reaction occurs when there is an electron-withdrawing 
group adjacent to the C-H bond to be deprotonated, which stabilizes the conjugate base.104 
In their research Magnus discovered that reacting the secondary nitrogen of the hydrazide 
with ethyl or methyl bromoacetate in acetonitrile or diglyme in the presence of a base, 
(Cs2CO3 or NaH), resulted in N-alkylation, which subsequently underwent E1cB elimination 
involving the acidic methylene hydrogen of the newly introduced alkoxycarbonylmethylene 
group to afford a carbamate in an excellent yield of 80-98% together with a dehydroglycine 
derivative side product, Scheme 64. The reaction could be conducted in two separate steps 
with isolation of the N-alkylated intermediate prior to the elimination step or in a one-pot 
procedure when using NaH as a base.105  
 
Scheme 64: E1cb N-N cleavage methodology developed by Magnus.  
 





4.2 Model study 
This method, published in 2009, had never before been applied to enantioselctively  
α-aminated substrates when this work began. In order to test the degree of its application, a 
model study was conducted on α-aminated decanal, which was chosen as a non-volatile 
aldehyde due to its long chain. Owing to the presence of a nucleophilic primary hydroxyl 
group in the α-hydrazino alcohol product produced after α-amination of decanal with proline 
and DBAD, application of the base-mediated Magnus procedure would inevitably cause 
cyclisation to form an N-substituted oxazolidinone. Thus the α-aminated product was first 
converted into an oxazolidinone-hydrazide using 1 M sodium hydroxide (NaOH). The three-
step sequence from decanal to the (R)-oxazolidinone-hydrazide was achieved in an overall 
yield of 92% and an ee of 92%, as shown in Scheme 65 below. 
 
Scheme 65: Formation of decanal oxazolidinine 26. 
The formation of oxazolidinone-hydrazide 26 was confirmed by the 1H NMR and 13C NMR 
spectra, shown in Figures 44 and Figure 45 respectively. The 1H NMR spectrum revealed 
aromatic signals integrating for five protons at 7.29 ppm and a benzyl (H3’) singlet at 5.12 
ppm for two protons. In addition, diastereotopic H5 protons were observed quite far apart at 
4.39 ppm and 3.90 ppm due to an alkyl shielding effect, while H4 integrating for one proton 
appeared between the two H5 signals, which was indicated by hsqc. The broad resonances 
were due to the presence of hydrazide rotamers. Additionally, the 13C NMR spectrum 
revealed two deshielded resonances at 68.2 ppm and 67.8 ppm for the C3’ and C5 carbons 
bonded to oxygen, while the C4 carbon, being bonded to nitrogen, appeared more upfield as 
expected at 56.9 ppm. In addition, the oxazolidinone carbonyl (C2) and the CBz carbonyl 
(C2’) resonances appeared in close proximity in the 13C NMR spectrum. Additional 
confirmation of 26 was obtained using high resolution mass spectroscopy, which found 
349.2131 for C19H29N2O4 [M+H]+; calculated mass was 349.2127.  





Figure 44: 1H NMR spectrum of decanal oxazolidinone. 
 
Figure 45: 13C NMR spectrum of the decanal oxazolidinone-hydrazide. 
Before proceeding with applying Magnus’ methodology, a conventional hydrogenolysis was 
first applied to oxazolidinone 26 (Scheme 66), which with Raney Nickel (2 eq.) gave a 
disappointing yield of 53% while hydrogenation with Pd-C (7 mol%) followed by Zn (37 eq.) 




in acetic acid (4 mL) gave a very low overall yield of 24%, with a full consumption of 
starting material as monitored by TLC in each case.  
 
Scheme 66: Hydrogenolysis of oxazolidinone-hydrazide 26. 
Formation of 27 was confirmed by 1H NMR and 13C NMR spectra, Figure 46 and Figure 47 
respectively. The prominent observations noted were the disappearance of the benzyl 
methylene and phenyl resonances in both spectra as well as the C2’ carbonyl carbon in the 
13C NMR spectrum. Furthermore, the resolved 1H NMR spectrum was due to the absence of 
rotamers that arose with the hydrazide. Likewise, further confirmation of 27 was obtained 
using HRMS that found 200.1652 for C11H22NO2 [M+H]+, which was in agreement with the 
calculated mass of 200.1651. 
 
 
Figure 46: 1H NMR spectrum of N-N cleaved decanal oxazolidinone. 





Figure 47: 13C NMR spectrum of N-N cleaved decanal oxazolidinone. 
4.3 Reaction study using Magnus’ methodology 
With a reference for the cleaved product now in hand, the oxazolidinone-hydrazide 26 was 
subjected to E1cB cleavage studies using Magnus’ conditions with either ethyl or methyl 
bromoacetate (2 eq.) in varying solvents (0.25 M), Scheme 67.  
 
Scheme 67: Application of Magnus’ conditions. 
Table 7 shows the results in which Magnus-1 refers to the one-pot procedure (without 
isolation of alkylated product) using Cs2CO3 in CH3CN, while Magnus-2 refers to using NaH 
in diglyme, also in a one-pot procedure. Dry solvents were used, as reaction times increased 











Table 7: Studies of Magnus’ conditions with varying solvents. 
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CH3CN 50-80  
 




THF 50-80  
 




DMF 50  
 
24 h 46 
 
Reactions conducted using the Magnus-1 procedure (Entries 1 and 2) were unsuccessful. 
Both the alkylating agent and the starting material were recovered (identified by NMR) even 
after extended reaction times of more than 2 days. An improvement was observed with the 
Magnus-2 conditions in which NaH was used as a base giving a very low yield of 16% with 
100% conversion after 17 hours (Entry 3). However, the low yield was to a degree a result of 
the difficulty in separating the product from diglyme even after multiple washings and 
chromatography. This led to the study of other solvents that could be easily removed by an 
aqueous work-up, but attempts in acetonitrile and THF also failed, with recovery of the 
starting material (Entries 4 and 5) even after extended reaction times at high temperatures. 
Progress was eventually achieved in DMF giving an improved yield of 46%. The poor 
outcomes compared to Magnus’ work may have been due to the change in substrate from that 
shown in Scheme 64 to our oxazolidinone-hydrazide. Whatever the reason it was though that 
switching to the more electrophilic bromomalonate would not only facilitate the N-alkylation 
step but also the E1cB elimination on account of the proton being abstracted being more 
acidic due to the presence of two electron-withdrawing groups in the reagent,  (Scheme 68).  
Table 8 shows a preliminary set of results varying the various reaction parameters of base, 
solvent, reagent equivalents, and reaction temperature. 





Scheme 68: New E1cB conditions. 
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(0.25 M) 
































CH3CN  5 h 50 80 
 
Although there were many parameter changes, the mini-study identified that using Cs2CO3 in 
CH3CN at room temperature at two equivalents of bromomalonate and 2.5 equivalents of 
base looked promising (entry 4), giving a 64% yield after chromatography. Heating the 
reaction with 5 equivalents each increased the yield to 80% (entry 8), which, however, was 
not cost efficient.  
Consequently, the conditions of entry 4 in Table 8 were applied to hemiaminal hydrazide 16 
with diethyl bromomalonate in acetonitrile at 0 °C, room temperature and 50 °C, but 
unfortunately the reaction was unsuccessful, with recovery of both starting materials at 0 °C 




and room temperature after work-up, and multiple unidentifiable spots at higher temperature, 
Scheme 69. Therefore, cleavage of the hemiaminal hydrazide remained using Raney Nickel. 
However, a study on other α-aminated aldehydes was pursued to explore the scope of the 
bromomalonate reaction.    
 
Scheme 69: Attempted Alkylation of hemiaminal hydrazide 16. 
4.4 New methodology applied to other simple aldehydes 
Hence the study was resumed with extension to other oxazolidinone-hydrazides (26, 28, 30, 
32) derived from other simple aldehydes such as propanal, iso-valeraldehyde and 
heptaldehyde, in which it was decided to retain the stoichiometry of the reagents in entry 4 
but also change the  relatively expensive caesium carbonate base to the cheaper potassium 
carbonate, Scheme 70.  
 
Scheme 70: Extention of E1cb elimination to other aldehydes. 
Oxazolidinone-hydrazides 26, 28, 30 and 32 in high ee were converted to cleaved products 
27, 29, 31, and 33 using the new optimized conditions, and the results are shown in Table 9 in 
which the yield and ee in the left-hand column refers to the results for aldehyde -amination 

































































































































Gratifyingly K2CO3 proved to improve the yield of the cleaved product 27 (R = Oct) from 
64% (with Cs2CO3; entry 1) to 90% as well as promote a marginal improvement for 32 (entry 
4; R = Pent) from 63% to 76% respectively, albeit that the reactions in entry 4 failed to go to 
completion. However, for smaller chains Cs2CO3 proved to give superior yields in lower 
reaction times (entries 2 and 3).  A solvent compatibility study with K2CO3 was conducted 
using oxazolidinone-hydrazide 26, and the results shown in Table 10 indicate that acetonitrile 
was indeed the best solvent, giving the highest yield in the shortest time. Reactions in DMF 
and toluene gave low yields, with completion of the reactions only possible by adding extra 
base and heating at 50 oC. Methanol gave no yield, with the degradation of bromomalonate 
observed on TLC.  
Table 10: Solvent study using decanal oxazolidinone. 
Entry Solvent Temp. Time  Yield % 
1 Acetonitrile RT 23 hrs 90 
2 DMF RT – 50 oC 3 d 30 
3 Toluene RT -50 oC 3 d 44 
4 Methanol RT 43 hrs 0 




4.5 Derivatization of oxazolidinones 
Owing to the non-UV activity of the cleaved products, derivatization of the oxazolidinone 
NH using benzyl chloroformate was conducted to install a UV-active chromophore for 
measuring the ees. In the event, sodium hydride (NaH) was used as a base to deprotonate the 
oxazolidinone forming an anion strong enough to attack the reagent through a SNAc reaction, 
Scheme 71. Figure 48 shows the 1H NMR and 13C NMR spectra of the CBz-derivatized  
propanal oxazolidinone 29a as representative, with evidence of formation indicated by the 
reappearance of benzyl methylene (Bn) and phenyl resonances in the place of an NH signal, 
and a C=O resonance appearing in the 13C NMR spectrum. 
 
Scheme 71: Derivatization of N-N cleaved oxazolidinones. 
 






Figure 48: 1H NMR and 13C NMR spectra of cbz-derivatized propanal oxazolidinone. 
 
Table 11 shows a comparison of ees of oxazolidinones 26, 28, 30 and 32 before cleavage 
against those obtained after derivatization on cleaved product 27, 29, 31 and 33 and results 















Table 11: Derivatization results. 
Entry Oxazolidinone ee (%) Derivatized cleaved 
product 






















































4.6 Extension to functionalized aldehydes 
To explore scope the methodology was extended to a range of functionalized aldehydes 
containing various unsaturated functional groups. Fully assigned 1H NMR spectra for one of 
the oxazolidinone hydrazides 36 is shown in Figure 49 together with its cleaved product 37, 
which show a significant sharpening of the resonances in the latter as a result of rotamer 
disappearance.  
 





Figure 49: Comparison of the 1H NMR spectra of pyridine functionalized oxazolidinone-
hydrazide and its cleaved product. 
Table 12 below shows the results obtained for the full series of oxazolidinone-hydrazides 
together with their cleaved products, Scheme 72.  
 
Scheme 72: α-Amination reaction followed by E1cB elimination. 
Formation of the oxazolidinone-hydrazides via enantioselective amination followed by ring 
closure gave high yields in the range 72% - 91% and high ees of 86% - 95%. Thereafter, 
E1cB cleavage results gave high yields for both bases although a greater advantage lay with 
the Cs2CO3 in which reaction times were in the range between 2 to 5 hours as compared to 24 
hours for K2CO3. An exception was observed with bis-acetal 43, which formed over an 
extended reaction time of 48 hours with both bases and gave a lower yield of 57% with 
Cs2CO3 (Entry 5). Comparison of the oxazolidinone-hydrazide and cleaved oxazolidinone ees 




indicated negligible racemization as before (Entries 1 to 3). Derivatization of 41 and 43 to 
install a UV-active CBz functionality for ee determination was unsuccessful owing to the 
instability of the substrates. 
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a. Yield and ee after amination, * Obtained from α-hydrazino alcohol. 
In conclusion, an improved methodology has been developed for the N-N cleavage of 
oxazolidinone-hydrazides derived from straight-chain aldehydes via an E1cB modified 
Magnus protocol using bromomalonate and either  K2CO3 or Cs2CO3 as base. The success of 
this procedure on oxazolidinone-hydrazides, while failing on the hemiaminal open hydrazide, 
possibly suggests a stereoelectronic element involving appropriate orbital alignment 
operating within the oxazolidinone as opposed to the open hydrazide, although further 
experimental support for this idea will need to be obtained, Scheme 73. However, the 




mystery as to why Magnus’ procedure on our oxazolidinone hydrazides was virtually 
ineffective is not understood. 
 
Scheme 73: Assisted elimination through delocalization. 
 





Conclusion and Future work 
5.1 Conclusion 
The use hemiaminals as masked aldehydes was proven successful through asymmetric  
α-amination of N-CBz and N-Boc protected hemiaminals with L-proline and DIAD, DBAD 
or DTBAD which were synthesized from 2-pyrrolidinone. Cleavage of the N-N bond of the 
resultant hydrazides was achieved with excess Raney Nickel followed by oxidation with PCC 
to afford the chiral α-aminated lactams with high ees of 78% and 86%.  
A new methodology was also developed for the N-N cleavage of the oxazolidinone 
hydrazides via an E1cB protocol using diethyl bromomalonate and a base (Cs2CO3 or K2CO3) 
which gave high yields and ees. Successful synthesis was established using various 
spectroscopic and analytical techniques, such as 1H NMR, 13C NMR, IR and mass 
spectrometry. 
5.2 Future work 
Future work would include the extension of the synthesis to six-membered (2-piperidinone) 
rings with exocyclic carbonyl as masked aldehydes, Scheme 74. 
 
Scheme 74: α-Amination, cleavage and oxidation of six-membered hemiaminal. 
 






6.1 General procedures  
All reactions were carried out in oven-dried glassware. Dry solvents were distilled under 
nitrogen before being used: acetonitrile from calcium hydride, tetrahydrofuran from sodium 
and benzophenone and dichloromethane from phosphorous pentoxide. All reagents and 
solvents were used without further purification from commercial sources. Thin Layer 
Chromatography analysis was carried out on aluminium sheets pre-coated with silica (Merck 
Silica Gel 60 F254), which was visualized by ultraviolet light and sprayed with ninhydrin or a 
2.5% solution of anisaldehyde in a mixture of sulfuric acid under heat. Column 
chromatography was carried out using silica gel (Fluorochem Silica Gel 60, 40-63 micron) as 
the stationary phase.  
 
Nuclear Magnetic Resonance spectra were recorded in CDCl3 solutions using a Bruker 
Avance III 400 MHz or a Varian Unity XR (300 and 400 MHz) or Varian Mercury 300 
spectrometer for 1H NMR and a Bruker Ultrashield 400 Plus (101 MHz) or a Bruker Avance 
III (75 MHz) for 13C NMR. Chemical shifts are reported relative to tetramethylsilane as the 
internal standard at 0.00 ppm for 1H NMR and CDCl3 at 77.16 ppm for 13C NMR as the 
internal standard. Spectral features for 1H NMR were recorded in the following order:  
chemical shift (δH, ppm); multiplicity; coupling constant(s) (J, Hz); number of protons; 
assignment. 13C NMR spectral data is recorded in the form: chemical shift (δC, ppm); 
assignment.  
 
High-resolution mass spectra (HRMS) were obtained using a Waters Synapt G2 instrument. 
Infrared (IR) spectra were obtained on a Bruker Platinim ATR Tensor 27 or Perkin Elmer 
uATR Two spectrometer instruments with neat samples. Spectral features are tabulated as 
wavenumbers (cm-1). Enantiomeric excess (ee) measurements were carried out by high 
pressure liquid chromatography (HPLC) on an Agilent 1220 Infinity LC series machine using 
a Chiralpak AD or OD column (250 x 4.6 mm) with a chiral stationary phase. All known 
compounds afforded as solids were pure enough to proceed to the next step unless stated 
otherwise. 
 




6.2 Synthesis and Characterization of products 




To a solution of 2,5-pyrrolidinedione (2.50 g, 25.2 mmol, 1.0 eq.) in DMF (30 mL) was 
added anhydrous potassium carbonate (4.18 g, 30.3 mmol, 1.2 eq.) followed by benzyl 
bromide (3.00 mL, 25.2 mmol, 1.0 eq.) and the reaction mixture was refluxed overnight at  
55 oC. The reaction mixture was then cooled to room temperature and water (200 mL) was 
added forming a precipitate. The precipitate was filtered, washed with water and dried to 
afford compound 1 (3.34 g, 70%) as a colourless solid. 1H NMR spectroscopic analysis 
showed it to be pure enough to proceed to the next step. 
δH (300 MHz, CDCl3) 7.36 – 7.14 (m, 5H, Ar-H), 4.58 (s, 2H, H-6), 2.61 (s, 4H, H-4, H-3); 
δC (101 MHz, CDCl3) 176.9 (C-5, C-2), 136.0 (C-7), 129.0 (C-8), 128.8 (C-9), 128.1 (C-10), 




To a solution of compound 1 (1.00 g, 5.29 mmol, 1.0 eq.) in a mixture (3 : 1) of MeOH  
(30 mL ) and DCM (10 mL) at -40 oC was added sodium borohydride (999 mg, 26.4 mmol, 
5.0 eq.) in portions and the reaction mixture was stirred at -40 oC until the starting material 
was consumed. The reaction mixture was then quenched with aqueous ammonium chloride 
(30 mL) at -40 oC and allowed to warm to room temperature. The mixture was then extracted 




with dichloromethane (3 x 50 mL) and the combined organic layers were dried over 
magnesium sulfate and concentrated. The residue was chromatographed on silica gel with an 
ethyl acetate / hexane (4 : 6) mixture to afford compound 2 (688 mg, 68%) as a colourless 
solid. 
δH (400 MHz, CDCl3) 7.29 - 7.17 (m, 5H, Ar-H), 5.02 (t, J = 5.3 Hz, 1H, H-5), 4.76  
(d, J = 8.0 Hz, 1H, H-6), 4.15 (d, J = 6.0 Hz, 1H, H-6), 2.64 – 2.50 (m, 1H, H-3), 2.35 - 2.16  
(m, 2H, H-4), 1.82 (t, J = 8.0 Hz, 1H, H-3); δC (101 MHz, CDCl3) 174.7 (C-2), 136.8 (C-7), 




A solution of glutaric acid (2.00 g, 15.1 mmol, 1.0 eq.) in acetyl chloride (20.0 mL,  
280 mmol, 18.5 eq.) was refluxed at 55 oC for 2 hours. The excess acetyl chloride was 
removed in vacuo and the residue dried under high vacuum for 1 hour. The residue was then 
dissolved in THF (40 mL) and benzylamine (3.00 mL, 27.4 mmol, 1.8 eq.) was added and the 
mixture was stirred at room temperature for 18 hours. The mixture was then concentrated and 
re-dissolved in acetyl chloride (30.0 mL, 420 mmol, 28 eq.) which was refluxed for a further 
24 hours, upon which the solution was concentrated and dissolved in ethyl acetate (30 mL). 
This was then washed with saturated sodium carbonate (50 mL) and the organic layer was 
dried over magnesium sulfate and concentrated. The crude residue was chromatographed on 
silica gel using an ethyl acetate / hexane (4 : 6) mixture to give compound 3 (2.63 g, 88%) as 
a colourless oil. 
δH (300 MHz, CDCl3) 7.30 - 7.08 (m, 5H, Ar-H), 4.85 (s, 2H, H-7), 2.55  
(t, J = 5.0 Hz, 4H, H-3, H-5), 1.82 (pent, J = 5.4 Hz, 2H, H-4); δC (101 MHz, CDCl3) 172.5 










To a solution of compound 3 (200 mg, 0.984 mmol, 1.0 eq.) in a mixture (3 : 1) of MeOH  
(9 mL) and DCM (3 mL) at -40 oC was added sodium borohydride (186 mg, 4.92 mmol,  
5.0 eq.) in portions and the reaction mixture was stirred at -40 oC until the starting material 
was consumed. The reaction mixture was then quenched with aqueous ammonium chloride 
(20 mL) at -40 oC and allowed to warm to room temperature. The mixture was then extracted 
with dichloromethane (3 x 50 mL) and the combined organic layers were dried over 
magnesium sulfate and concentrated. The residue was chromatographed on silica gel with an 
ethyl acetate / hexane (4 : 6) mixture to afford compound 4 (162 mg, 80%) as a colourless 
solid. 
δH (400 MHz, CDCl3) 7.32 - 7.13 (m, 5H, Ar-H), 5.01 (d, J = 6.0 Hz, 1H, H-7), 4.85  
(t, J = 5.3 Hz, 1H, H-6), 4.29 (d, J = 8.0 Hz, 1H, H-7), 2.60 - 2.50 (m, 1H, H-3), 2.47 - 2.34 
(m, 1H, H-3), 2.11 - 1.99 (m, 1H, H-5), 1.95 - 1.81 (m, 2H, H-5, H-4), 1.78 -1.66 (m, 1H,  
H-4); δC (101 MHz, CDCl3) 170.7 (C-2), 137.8 (C-8), 128.8 (C-9), 128.3 (C-10), 127.6  




To a solution of glutarimide (500 mg, 4.42 mmol, 1.0 eq.) in DMF (5 mL) at room 
temperature was added potassium carbonate (1.20 g, 8.84 mmol, 2.0 eq) and  
4-methoxybenzyl chloride (0.60 mL, 4.42 mmol, 1.0 eq). The reaction mixture was left to stir 
overnight before being diluted with water (100 mL) and extracted with dichloromethane  
(3 × 15 mL). The combined organic layers were dried over magnesium sulfate and 




concentrated. Crystallization from a mixture of DCM and hexane afforded compound 5  
(990 mg, 96%) as a colourless solid. 
δH (300 MHz, CDCl3) 7.69 (d, J = 4.5 Hz, 2H, H-9), 6.72 (d, J = 4.5 Hz, 2H, H-10), 4.81  
(s, 2H, H-7), 3.70 (s, 3H, H-12), 2.57 (d, J = 4.0 Hz, 4H, H-5, H-3), 1.84 (pent, J = 5.4 Hz, 
2H, H-4); δC (101 MHz, CDCl3) 172.5 (C-6, C-2), 159.1 (C-11), 130.6 (C-9), 129.8 (C-8), 




To a solution of compound 5 (400 mg, 1.71 mmol, 1.0 eq.) in a mixture (2 : 1) of MeOH  
(10 mL) and DCM (5 mL) at -20 oC was added sodium borohydride (195 mg, 5.14 mmol,  
5.0 eq.) and the reaction mixture was stirred at -20 oC overnight. The reaction mixture was 
quenched with aqueous ammonium chloride (20 mL) at -20 oC and allowed to warm to room 
temperature with stirring. The mixture was then extracted with dichloromethane (3 x 30 mL) 
and the combined organic layers were dried over magnesium sulfate and concentrated. The 
residue was chromatographed on silica gel with an ethyl acetate / hexane (1 : 1) mixture to 
afford compound 6 (160 mg, 66%) as a colourless solid with recovery of the starting material 
(240 mg, 1.03 mmol), 60% conversion.  
δH (300 MHz, CDCl3) 7.10 (d, J = 4.5 Hz, 2H, H-9), 6.78 (d, J = 4.5 Hz, 2H, H-10), 5.94  
(dt, J = 2.0 Hz, 1H, O-H), 5.05 (dt, J = 5.2 Hz, 1H, H-6), 4.54 (s, 2H, H-7), 3.72 (s, 3H,  
H-12), 2.49 (t, J = 5.0 Hz, 2H, H-3), 2.30 - 2.20 (m, 4H, H-5, H-4); δC (101 MHz, CDCl3) 
169.5 (C-2), 159.2 (C-11), 129.5 (C-9), 129.2 (C-8), 114.2 (C-10), 79.2 (C-6), 55.4 (C-12), 








tert-Butyl 2,6-dioxopiperidine-1-carboxylate, 7110 
 
To a solution of 2,6-piperidinedione (5.00 g, 60.0 mmol, 1.0 eq.) in CH3CN (150 mL) at 
room temperature, was added di-tert-butyl dicarbonate (13.0 mL, 60.0 mmol, 1.0 eq) 
followed by 4-dimethylaminopyridine (1.50 g, 12.0 mmol, 0.2 eq.). The reaction mixture was 
stirred for 18 hours at room temperature before being quenched with aqueous ammonium 
chloride (50 mL) and extracted with ethyl acetate (3 x 100 mL), dried over magnesium 
sulfate and concentrated. The residue was chromatographed on silica gel with an ethyl acetate 
/ hexane (1 : 1) mixture to give compound 7 (12.2 g, 95%) as a yellow oil. 
δH (400 MHz, CDCl3) 2.68 - 2.52 (m, 4H, H-5, H-3), 2.04 -1.90 (m, 2H, H-4), 1.44 (s, 9H,  
H-9); δC (101 MHz, CDCl3) 170.2 (C-6, C-2), 149.1 (C-7), 86.4 (C-8), 32.0 (C-5, C-3), 27.6 
(C-9), 17.2 (C-4). 
 
tert-Butyl ((6-hydroxypentanoyl)amino)carbamate, 8a 
 
To a solution of compound 7 (200 mg, 0.938 mmol, 1.0 eq.) in a mixture (3 : 1) of MeOH  
(9 mL ) and DCM (3 mL) at -40 oC was added sodium borohydride (177 mg, 4.69 mmol,  
5.0 eq.) in portions and the reaction mixture was stirred at -40 oC until the starting material 
was consumed. The reaction mixture was then quenched with aqueous ammonium chloride 
(20 mL) at -40 oC and allowed to warm to room temperature. The mixture was then extracted 
with dichloromethane (3 x 50 mL) and the combined organic layers were dried over 
magnesium sulfate and concentrated. The residue was chromatographed on silica gel with an 
ethyl acetate / hexane (4 : 6) mixture to afford compound 8 (139 mg, 68%) as a colourless oil. 
IR vmax / cm-1 3322 (N-H), 3275 (O-H), 1699 (2 x C=O); HRMS (ESI): 240.1215 [M+Na]+, 
C10H19NNaO4 requires 240.1216; δH (400 MHz, CDCl3) 7.82 (s, 1H, N-H), 3.57  




(t, J = 4.0 Hz, 2H, H-6), 2.68 (t, J = 5.3 Hz, 2H, H-3), 2.39 (s, 1H, O-H), 1.71 - 1.63 (m, 2H, 
H-4), 1.59 - 1.51 (m, 2H, H-5), 1.42 (s, 9H, H-4’); δC (101 MHz, CDCl3) 171.2 (C-2), 157.3 




To a solution of 2,5-pyrrolidinedione (991 mg, 10.2 mmol, 1.7 eq.) dissolved in DMF (3 mL) 
and THF (10 mL) at 0 oC, was added sodium hydride (319 mg, 60%, 7.80 mmol, 1.3 eq.) and 
the reaction mixture was stirred for 15 minutes at 0 oC. Benzyl chloroformate (0.90 mL,  
6.00 mmol, 1.0 eq.) was then added to the reaction mixture which was left to stir at 0 oC until 
complete. The reaction mixture was then quenched with aqueous ammonium chloride  
(20 mL) and extracted with ethyl acetate (3 x 50 mL), dried with magnesium sulfate and 
concentrated. The residue was chromatographed on silica gel with an ethyl acetate / hexane 
(3 : 7) mixture to afford compound 9 (714 mg, 51%) as a colourless solid.  
IR vmax / cm-1 1785 (C=O), 1779 (C=O), 1798 (C=O); δH (400 MHz, CDCl3) 7.40 - 7.25  
(m, 5H, Ar-H), 5.31 (s, 2H, H-7), 2.72 (s, 4H, H-4, H-3); δC (75 MHz, CDCl3) 176.6 (C-5,  
C-2), 152.3 (C-6), 134.1 (C-8), 128.8 (C-9), 128.7 (C-10), 128.4 (C-11), 70.0  








To a suspension of lithium aluminium hydride (60.0 mg, 1.60 mmol, 1.0 eq.) in THF (10 mL) 
at -78 oC was added dropwise compound 9 (371 mg, 1.60 mmol, 1.0 eq.) in THF (5 mL) over 
30 minutes. After completion the mixture was warmed to -40 oC, quenched with 1M HCl  
(10 mL) and extracted with ethyl acetate (3 × 30 mL). The organic layers were washed with 
brine (2 × 20 mL), dried over magnesium sulfate and concentrated. The residue was 
chromatographed on silica gel with an ethyl acetate / hexane (2 : 8) mixture to afford 
compound 10 (113 mg, 30%) as a yellow oil and an approximately 4 : 1 mixture of N-CO 
rotamers. 
IR vmax / cm-1 1658 (2 x C=O); HRMS (ESI): 258.0746 [M+Na]+, C12H13NNaO4 requires 
258.0742; δH (300 MHz, CDCl3) major rotamer 7.39 - 7.21 (m, 5H, Ar-H), 5.68  
(d, J = 5.0 Hz, 1H, H-5), 5.25 (s, 2H, H-7), 3.77 (brs, 1H, OH), 2.78 - 2.63 (m, 1H, H-3),  
2.44 - 2.31 (m, 1H, H-3), 2.22 - 2.07 (m, 1H, H-4), 1.99 - 1.88 (m, 1H, H-4); δC (75 MHz, 
CDCl3) 175.5 (C-2), 152.6 (C-6), 135.3 (C-8), 128.7 (C-9), 128.6 (C-10), 128.5 (C-11), 86.3 
(C-5), 65.5 (C-7), 27.6 (C-4), 26.5 C-3); δH minor rotamer 5.77 (d, J = 5.2 Hz, 1H, H-5);  
δC minor rotamer 86.6 (C-5). 
 
Methyl 5-(((benzyloxy)carbonyl)amino)-5-oxobutanoate, 10a 
 
To a suspension of lithium aluminium hydride (60.0 mg, 1.60 mmol, 1.0 eq.) in THF (10 mL) 
at -78 oC was added dropwise compound 9 (371 mg, 1.60 mmol, 1.0 eq.) in THF (5 mL) over 
30 minutes. After completion the mixture was warmed to -40 oC, quenched with 1M HCl  
(10 mL) and extracted with ethyl acetate (3 × 30 mL). The organic layers were washed with 
brine (2 × 20 mL), dried over magnesium sulfate and concentrated. The residue was 
chromatographed on silica gel with an ethyl acetate / hexane (2 : 8) mixture to afford 
compound 10a (276 mg, 65%) as a yellow oil. 
IR vmax / cm-1 3281 (N-H), 1678 (3 x C=O); HRMS (ESI): 279.0851 [M+Na]+, C13H15NNaO5 
requires 279.0854; δH (300 MHz, CDCl3) 7.57 (s, 1H, N-H), 7.32 - 7.27 (m, 5H, Ar-H), 5.10 
(s, 2H, H-7), 3.58 (s, 3H, H-1), 2.99 (t, J = 4.0 Hz, 2H, H-4), 2.56 (t, J = 5.0 Hz, 2H, H-3);  
δC (75 MHz, CDCl3) 172.8 (C-5), 172.3 (C-2), 150.3 (C-6), 135.7 (C-8), 128.9 (C-9), 128.5  
(C-10), 127.9 (C-11), 65.4 (C-7), 49.6 (C-1), 29.8 (C-3), 29.6 (C-4). 




6.2.3 Synthesis of hemiaminal type 2 
1-(Benzyloxycarbonyl)pyrrolidin-2-one, 11112 
 
To a solution of 2-pyrrolidinone (0.30 mL, 4.00 mmol, 2.0 eq.) in THF (10 mL) at 0 oC, was 
added sodium hydride (120 mg, 60%, 3.00 mmol, 1.5 eq.) and the reaction was stirred for  
15 minutes at 0 oC. This mixture was then added to a solution of benzyl chloroformate  
(0.30 mL, 2.00 mmol, 1.0 eq.) in THF (10 mL) cooled to 0 oC. The reaction was then stirred 
for 3 hours before being quenched with aqueous ammonium chloride (20 mL) and extracted 
with ethyl acetate (3 x 50 mL). The combined organic layers were dried over magnesium 
sulfate and concentrated. The crude residue was chromatographed on silica gel with an ethyl 
acetate / hexane (2 : 8) mixture to afford compound 11 (263 mg, 60%) as a yellow oil and a 
single  
N-CO rotamer. 
δH (300 MHz, CDCl3) 7.35 - 7.16 (m, 5H, Ar-H), 5.16 (s, 2H, H-7), 3.68 (t, J = 6.0 Hz, 2H, 
H-5), 2.39 (t, J = 6.0 Hz, 2H, H-3), 1.90 (pent, J = 6.0 Hz, 2H, H-4); δC (101 MHz, CDCl3) 
172.5 (C-2), 150.0 (C-6), 134.0 (C-8), 127.1 (C-9), 126.9 (C-10), 126.7 (C11), 66.4 (C-7), 




To a solution of compound 11 (500 mg, 2.28 mmol, 1.0 eq.) in a mixture (3 : 1) of MeOH  
(9 mL ) and DCM (3 mL) at -40 oC was added sodium borohydride (431 mg, 11.4 mmol,  
5.0 eq.) in portions and the reaction mixture was stirred at -40 oC for 5 hours. The reaction 




mixture was then quenched with aqueous ammonium chloride (20 mL) at -40 oC and allowed 
to warm to room temperature. The mixture was then extracted with dichloromethane  
(3 x 50 mL) and the combined organic layers were dried over magnesium sulfate and 
concentrated. The residue was chromatographed on silica gel with an ethyl acetate / hexane 
(1 : 1) mixture to give compound 12 (459 mg, 91%) as a colourless oil and an approximately 
2 : 1 mixture of N-CO rotamers. 
δH (400 MHz, CDCl3) major rotamer 7.35 (s, 5H, Ar-H), 5.55 - 5.51 (m, 1H, H-2), 5.16  
(s, 2H, H-7), 3.64 - 3.54 (m, 1H, H-5), 3.46 - 3.26 (m, 1H, H-5), 2.16 - 1.72 (m, 4H, H-4,  
H-3); δC (101 MHz, CDCl3) 155.6 (C-6), 136.6 (C-8), 128.6 (C-9), 128.2 (C-10), 128.0  
(C-11), 82.3 (C-2), 67.0 (C-7), 45.9 (C-5), 32.8 (C-3), 22.9 (C-4); δH minor rotamer  




To a solution of compound 12 (100 mg, 0.452 mmol, 1.5 eq.) in CH3CN (3 mL) was added  
L-proline (3.47 mg, 0.030 mmol, 0.1 eq.) and diisopropyl azodicarboxylate (60.9 mg,  
0.301 mmol, 1.0 eq.) and the reaction was left to stir at room temperature for 3 days in which 
it had turned colourless. The reaction mixture was then quenched with aqueous ammonium 
chloride (10 mL) and extracted with ethyl acetate (3 x 15 mL). The combined organic layers 
were dried over magnesium sulfate and concentrated. The residue was chromatographed on 
silica gel using an ethyl acetate / hexane (3 : 7) mixture to give compound 13 (117 mg, 92%) 
as a yellow oil and an approximately 2 : 1 mixture of diastereomers. 
IR vmax / cm-1 3384 (N-H), 3291 (O-H), 1684 (3 x C=O); HRMS (ESI): 446.1888 [M+Na]+, 
C20H29N3NaO7 requires 446.1903; δH (400 MHz, CDCl3) major isomer 7.26 (s, 5H, Ar-H), 
6.67 (s, 1H, NH), 5.50 - 5.34 (m, 1H, H-2), 5.41 (s, 2H, H-7), 4.90 - 4.84 (m, 2H, H-5’), 




 4.57 - 4.45 (m, 1H, H-3), 3.60 - 3.39 (m, 2H, H-5), 2.27 - 2.05 (m, 1H, H-4), 2.02 - 1.86  
(m, 1H, H-4), 1.29 - 102 (m, 12H, H-6’);  δC (101 MHz, CDCl3) major isomer 156.9 (C-6), 
155.4 (C-4’, C-3’), 136.3 (C-8), 128.6 (C-9), 128.2 (C-10), 128.0 (C-11), 84.3 (C-2), 70.8  
(C-5’), 67.3 (C-7), 64.0 (C-3), 43.1 (C-5), 34.0 (C-4), 22.1 (C-6’); δH minor isomer 6.51  




To a solution of 2-pyrrolidinone (5.00 g, 60.0 mmol, 1.0 eq.) in CH3CN (150 mL) at room 
temperature, was added di-tert-butyl dicarbonate (13.0 g, 60.0 mmol, 1.0 eq) followed by 
 4-dimethylaminopyridine (1.50 g, 12.0 mmol, 0.2 eq.). The reaction mixture was stirred 
overnight at room temperature, before being quenched with aqueous ammonium chloride  
(50 mL) and extracted with ethyl acetate (3 x 100 mL), dried over magnesium sulfate and 
concentrated. The residue was chromatographed on silica gel with an ethyl acetate / hexane 
(1 : 1) mixture to give compound 14 (10.6 g, 95%) as a yellow oil and as a single C-N 
rotamer. 
δH (300 MHz, CDCl3) 3.67 (t, J = 5.0 Hz, 2H, H-5), 2.43 (t, J = 5.0 Hz, 2H, H-3), 1.93 (pent, 
J = 6.0 Hz, 2H, H-4), 1.45 (s, 9H, H-8); δC (101 MHz, CDCl3) 173.8 (C-2), 149.8 (C-6), 82.0 




To a solution of compound 14 (500 mg, 2.70 mmol, 1.0 eq.) in a mixture (3 : 1) of MeOH  
(15 mL) and DCM (5 mL) at -40 oC was added sodium borohydride (510 mg, 13.5 mmol,  




5.0 eq.) and the reaction mixture was stirred at -40 oC for 5 hours until the starting material 
was consumed. The reaction mixture was quenched with aqueous ammonium chloride  
(15 mL) at -40 oC and allowed to warm to room temperature with stirring. The mixture was 
then extracted with dichloromethane (3 x 30 mL) and the combined organic layers were dried 
over magnesium sulfate and concentrated. The residue was chromatographed on silica gel 
with an ethyl acetate / hexane (2 : 8) mixture to afford compound 15 (465 mg, 92%) as a 
colourless oil and as an approximately 2 : 1 mixture of N-CO rotamers. 
δH (400 MHz, CDCl3) major rotamer 5.45 - 5.40 (m, 1H, H-2), 4.01 (br s, 1H, OH),  
3.49 - 4.34 (m, 1H, H-5), 3.28 - 3.12 (m, 1H, H-5), 2.08 - 1.63 (m, 4H, H-4, H-3), 1.40  
(s, 9H, H-8); δC (300 MHz, CDCl3) major rotamer 155.1 (C-6), 81.5 (C-2), 79.9 (C-7), 45.9  
(C-5), 32.8 (C-3), 28.4 (C-8), 22.7 (C-4); δH minor rotamer 5.34 - 5.27 (m, 1H, H-2);  





To a solution of compound 15 (100 mg, 0.534 mmol, 1.5 eq.) in CH3CN (3 mL) was added  
L-proline (4.10 mg, 0.036 mmol, 0.1 eq.) and dibenzyl azodicarboxylate (106 mg,  
0.356 mmol, 1.0 eq.).  Aqueous ammonium chloride (10 mL) was added once the reaction 
mixture had become colourless (3 days) and was extracted with ethyl acetate (3 x 20 mL). 
The combined organic layers were dried over magnesium sulfate and concentrated. The 
residue was chromatographed on silica gel with an ethyl acetate / hexane (2 : 8) mixture to 
give compound 16 (156 mg, 90%) as a yellow oil and as an approximately 2 : 1 mixture of 
diastereomers and ee of 83% and 84%. 
IR vmax / cm-1 3300 (N-H), 3185 (O-H), 1696 (3 x C=O); HRMS (ESI): 508.2066 [M+Na]+, 
C25H31N3NaO7 requires 508.2060; δH (400 MHz, CDCl3) major isomer 7.21 (s, 10H, Ar-H), 
6.75 (s, 1H, NH), 5.44 - 5.25 (m, 1H, H-2), 5.15 - 4.95 (m, 4H, H-5’), 4.63 - 4.48 (m, 1H,  




H-3), 3.52 - 3.25 (m, 2H, H-5), 2.21 - 2.06 (m, 1H, H-4), 1.98 - 1.86 (m, 1H, H-4), 1.37  
(s, 9H, H-8) δC (300 MHz, CDCl3) major isomer  156.1 (C-6), 155.6 (C-3’), 154.9 (C-4’), 
135.6 (C-6’), 128.5 (C-7’), 128.2 (C-8’), 127.8 (C-9’), 83.0 (C-7), 80.7 (C-2), 68.4 (C-5’), 
53.7 (C-3), 44.6 (C-5), 28.2 (C-8), 25.3 (C-4); δH minor isomer 6.66 (s, 1H, N-H), 4.11 - 3.93 
(m, 1H, H-3); δC minor isomer 79.8 (C-2), 43.0 (C-5); Chiralpak AD hexane / i-propanol  
(1 : 9), flow rate = 1mL / min, λ = 254 nm; Rt (major diastereomer 1) = 26.09 min, Rt (minor 
diastereomer 1) = 30.83 min; Rt (major diastereomer 2) = 33.98 min, Rt (minor diastereomer 






To a solution of 15 (100 mg, 0.534 mmol, 1.5 eq.) in acetonitrile (3 mL) was added L-proline 
(4.10 mg, 0.036 mmol, 0.1 eq.) and diisopropyl azodicarboxylate (72.0 mg, 0.356 mmol,  
1.5 eq.) and the reaction was left to stir at room temperature for 6 days after which it had 
become colourless. The reaction mixture was quenched with aqueous ammonium chloride 
(10 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic layers were 
dried over magnesium sulfate and concentrated under reduced pressure. The residue was 
chromatographed over silica gel using ethyl acetate / hexane (3 : 7) mixture to give 
compound 17 (111 mg, 80%) as a colourless oil and 2 : 1 mixture of diastereomes. 
IR vmax / cm-1 3380 (N-H), 3290 (O-H), 1680 (3 x C=O); HRMS (ESI): 412.2054 [M+Na]+, 
C17H31N3NaO7 requires 412.2060; δH (400 MHz, CDCl3) major isomer 6.56 (s, 1H, N-H), 
5.46 - 5.29 (m, 1H, H-2), 5.01 - 4.83 (m, 2H, H-5’), 4.67 - 4.44 (m, 1H, H-3), 3.57 - 3.41  
(m, 1H, H-5), 3.27 - 3.11 (m, 1H, H-5), 2.32 - 2.13 (m, 1H, H-4), 2.02 - 1.86 (m, 1H, H-4), 
1.38 (s, 9H, H-8), 1.22 - 1.06 (m, 12H, H6’); δC (151 MHz, CDCl3) major isomer 156.8  
(C-6), 156.0 (C-3’), 155.4 (C-4’), 80.6 (C-2), 70.2 (C-5’), 57.8 (C-3), 44.7 (C-5), 28.5 (C-8), 




25.8 (C-4), 21.1 (C-6’); δH minor isomer 6.49 (s, 1H, N-H), 4.12 - 3.98 (m, 1H, H-3);  





To a solution of 15 (100 mg, 0.534 mmol, 1.5 eq.) in acetonitrile (3 mL) was added L-proline 
(4.10 mg, 0.036 mmol, 0.1 eq.) and di-tert-butyl azodicarboxylate (82.0 mg, 0.356 mmol,  
1.0 eq.) and the reaction was left to stir at room temperature for 4 days after which it had 
turned colourless. The reaction mixture was quenched with aqueous ammonium chloride  
(10 mL) and extracted with ethyl acetate (3 x 30 mL). The combined organic layers were 
dried over magnesium sulfate and concentrated. The residue was chromatographed over silica 
gel using ethyl acetate / hexane (3 : 7) mixture to give compound 18 (68 mg, 46%) as a 
colourless oil and 2 : 1 mixture of diastereomes. 
IR vmax / cm-1 3389 (N-H), 3291 (O-H), 1700 (3 x C=O); HRMS (ESI): 440.2375 [M+Na]+, 
C19H35N3NaO7 requires 440.2373; δH (400 MHz, CDCl3) major isomer 6.56 (s, 1H, N-H), 
5.42 - 5.20 (m, 1H, H-2), 4.56 - 4.36 (m, 1H, H-3), 3.56 - 3.08 (m, 2H, H-5), 2.28 - 1.81  
(m, 2H, H-4), 1.49 - 1.27 (m, 27H, H-8, H-6’); δC (101 MHz, CDCl3) major isomer 156.1  
(C-6), 155.1 (C-3’), 154.8 (C-4’), 84.5 (C-2), 82.1 (C-7), 80.4 (C-5’), 63.6 (C-3), 43.3 (C-5), 
28.6 (C-8, C-6’), 25.9 (C-4); δH minor isomer 6.30 (s, 1H, N-H), 4.05 (m, 1H, H-3); δC minor 














To a solution of compound 16 (230 mg, 0.474 mmol, 1.0 eq.) in DCM (5 mL) was added 
pyridinium chlorochromate (306 mg, 1.42 mmol, 3.0 eq.) and the reaction mixture was stirred 
at room temperature for 5 hours, after which it was filtered through Celite® and the solvent 
removed in vacuo.  The crude residue was chromatographed on silica gel with an ethyl 
acetate / hexane mixture (3 : 7) to afford compound 16a (156 mg, 68%) as a colourless oil 
with ee of 84% and isomer ratio of (92 : 8). 
IR vmax / cm-1 3377 (N-H), 1713 (2 x C=O), 1787 (C=O), 1798 (C=O); HRMS (ESI): 
506.1904 [M+Na]+, C25H29N3NaO7 requires 506.1903; δH (400 MHz, CDCl3) 7.24 (s, 10H, 
Ar-H), 6.75 (s, 1H, NH), 5.16 - 4.95 (m, 5H, H-5’, H-3), 3.81 - 3.65 (m, 1H, H-5),  
3.50 - 3.35 (m, 1H, H-5), 2.40 - 2.22 (m, 1H, H-4), 2.19 - 2.02 (m, 1H, H-4), 1.43 (s, 9H,  
H-8); δC (101 MHz, CDCl3) 169.8 (C-2), 155.6 (C-6), 149.9 (C-4’, C-3’), 135.5 (C-6’), 128.5 
(C-7’), 128.1 (C-8’), 127.8 (C-9’), 83.6 (C-7), 76.8 (C-3), 68.7 (C-5’), 42.6 (C-5), 28.0 (C-8), 
21.8 (C-4); Chiralpak AD hexane / i-propanol (1 : 9), 1mL / min, 254 nm;  










To a solution of 17 (150 mg, 0.385 mmol, 1.0 eq.) in DCM (3 mL) was added pyridinium 
chlorochromate (249 mg, 1.16 mmol, 3.0 eq.) and the reaction mixture was stirred at room 
temperature for 5 hours, filtered through Celite® and the solvent was concentrated. The crude 
residue was chromatographed over silica gel with ethyl acetate / hexane mixture (3 : 7) to 
afford compound 17a (99 mg, 67%) as a colourless oil with ee of 80% and isomer ratio of  
(89 : 11).  
IR vmax / cm-1 3261 (N-H), 141 (2 x C=O), 1695 (2 x C=O); HRMS (ESI): 410.1896 
[M+Na]+, C17H29N3NaO7 requires 410.1903; δH (400 MHz, CDCl3) 6.52 (s, 1H, N-H),  
4.96 - 4.80 (m, 2H, H-5’), 4.40 - 4.26 (m, 1H, H-3), 3.78 - 3.70 (m, 1H, H-5), 3.50 - 3.41  
(m, 1H, H-5), 2.35 - 2.20 (m, 1H, H-4), 2.15 - 1.99 (m, 1H, H-4), 1.46 (s, 9H, H-8),  
1.25 - 1.12 (m, 12H, H-6’); δC (101 MHz, CDCl3) 171.3 (C-2), 156.0 (C-3’, C-4’), 150.1  
(C-6), 83.6 (C-7), 71.2 (C-3), 70.2 (C-5’), 42.7 (C-5), 28.1 (C-8), 22.1 (C-6’), 17.1 (C-4); 
Chiralpak AD hexane / i-propanol (1 : 9), flow rate = 1 mL / min, λ = 254 nm;   





To a solution of 18 (150 mg, 0.287 mmol, 1.0 eq.) in DCM (3 mL) was added pyridinium 
chlorochromate (186 mg, 0.861 mmol, 3.0 eq.) and the reaction mixture was stirred at room 
temperature for 5 hours, filtered through Celite® and the solvent was concentrated under 
reduced pressure. The crude residue was chromatographed over silica gel with ethyl acetate / 
hexane mixture (3 : 7) to afford compound 18a (79 mg, 66%) as a colourless oil with an ee of 
68% and isomer ratio of (83 : 17).  
IR vmax / cm-1 3379 (N-H), 1798 (C=O), 1786 (C=O), 1715 (2 x C=O); HRMS 438.2218 
[M+Na]+, C19H33N3NaO7 requires 438.2220; δH (400 MHz, CDCl3) 6.34 (s, 1H, N-H),  




4.55 -4.52 (m, 1H, H-3), 3.61 - 3.12 (m, 2H, H-5), 2.32 - 1.85 (m, 2H, H-4), 1.53 - 1.32  
(m, 27H, H-8, H-6’); δC 171.8 (C-2), 156.2 (C-3’), 155.9 (C-4’), 151.4 (C-6), 81.6 (C-7), 80.1  
(C-5’), 73.5 (C-3), 38.7 (C-5), 29.3 (C-8, C-6’), 15.7 (C-4); Chiralpak AD hexane /  
i-propanol (1 : 9), flow rate = 1 mL / min, λ = 254 nm;  Rt (major) = 35.81 min,  
Rt (minor) = 40.22 min, 68% ee. 
 
tert-Butyl 3-((tert-butoxycarbonyl)amino)-2-hydroxypyrrolidine-1-carboxylate, 22 
 
 
To a solution of compound 16 (246 mg, 0.507 mmol, 1.0 eq.) in MeOH (5 mL) was added 
Raney Nickel (952 mg, 16.2 mmol, 32 eq.) in MeOH (2 mL) and the reaction mixture was 
purged with hydrogen then hydrogenated at room temperature and atmospheric pressure for  
6 hours. After this time, further Raney Nickel (952 mg, 16.2 mmol, 32 eq.) in MeOH (2 mL) 
was added and the reaction was left to stir for a further 18 hours under a hydrogen 
atmosphere. The mixture was then filtered through Celite® and the solvent evaporated in 
vacuo. The crude product 21 was then dissolved in THF (5 mL) and di-tert-butyl dicarbonate 
(332 mg, 1.52 mmol, 3.0 eq.) was added and the reaction was left to stir at room temperature 
for 15 hours. The reaction mixture was then quenched with aqueous ammonium chloride  
(10 mL) and extracted with ethyl acetate (3 x 20 mL). The combined organic layers were 
dried over magnesium sulfate and concentrated under reduced pressure. The residue was 
chromatographed over silica gel with an ethyl acetate / hexane (3 : 7) mixture to give 
compound 22 (180 mg, 65%) as a colourless oil with an approximately 2 : 1 mixture of 
isomers.  
IR vmax / cm-1 3387 (N-H), 3290 (O-H), 1722 (C=O), 1695 (C=O); HRMS (ESI): 302.1743 
[M+Na]+, C14H26N2NaO5 requires 302.1740; δH (300 MHz, CDCl3) major isomer 5.40 - 5.06 
(m, 1H, H-2), 4.79 - 4.65 (m, 1H, H-3), 4.12 - 3.85 (m, 1H, N-H), 3.56 - 3.26 (m, 2H, H-5), 
2.42 - 2.05 (m, 2H, H-4), 1.41 (s, 9H, H-8), 1.38 (s, 9H, H-4’); δC (75 MHz, CDCl3) major 




isomer 155.1 (C-2’), 155.0 (C-6), 85.5 (C-2), 80.9 (C-3’), 79.0 (C-7), 52.2 (C-3), 43.5 (C-5), 
29.6 (C-4), 28.5 (C-8), 28.5 (C-4’); δH minor isomer 5.11 (m, 1H, H-2); δC minor isomer 86.3 
(C-2). 
tert-Butyl 3-((tert-butoxycarbonyl)amino)-2-oxopyrrolidine-1-carboxylate, 23 
 
To a solution of 22 (90.0 mg, 0.298 mmol, 1.0 eq.) in DCM (5 mL) was added pyridinium 
chlorochromate (192 mg, 0.893 mmol, 3.0 eq.) and the reaction mixture was stirred at room 
temperature for 12 hours, filtered through Celite® and the solvent was concentrated. The 
crude residue was chromatographed over silica gel with ethyl acetate / hexane mixture (1 : 1) 
to afford compound 23 (57 mg, 65%) as a yellow oil with an ee of 78% and an isomer ratio of 
(89 : 11). 
IR vmax / cm-1 3389 (N-H),  1725 (2 x C=O), 1698 (C=O); HRMS (ESI):  m / z 323.1586 
[M+Na]+, C14H24N2NaO5  requires 323.1583;  δH (400 MHz, CDCl3) 4.57 - 4.43 (m, 1H,  
H-3), 3.93 (s, 1H, NH), 3.51 - 3.24 (m, 2H, H-5), 2.34 - 2.14 (m, 2H, H-4), 1.44 - 1.32  
(m, 18H, H-8, H4’); δC (300 MHz, CDCl3) 171.6 (C-2), 150.0 (C-2’), 149.5 (C-6), 83.2 (C-7), 
79.9 (C-3’), 59.2 (C-3), 42.5 (C-5), 27.9 (C-8), 27.9 (C-4’), 22.3 (C-4); Chiralpak AD hexane 
/ i-propanol (1 : 9), flow rate = 1mL / min, λ = 254 nm; Rt (major) = 11.14 min,  
Rt (minor) = 11.98 min, 78% ee. 
tert-Butyl 2-hydroxy-3-((isopropoxycarbonyl)amino)pyrrolidine-1-carboxylate, 24 
 




To a solution of 17 (156 mg, 0.401 mmol, 1.0 eq.) in methanol (5 mL) was added Raney 
Nickel (1.50 g, 25.6 mmol, 64 eq.) dissolved in methanol (2 mL) and the reaction mixture 
was purged with hydrogen then hydrogenated at atmospheric pressure at 80 oC for 2 days. 
The mixture was then filtered through Celite® and concentrated under reduced pressure. The 
reaction mixture was dissolved with aqueous ammonium chloride (20 mL) and extracted with 
ethyl acetate (3 x 50 mL). The combined organic layers were dried over magnesium sulfate 
and concentrated. The residue was chromatographed over silica gel with ethyl acetate  
/  hexane (3 : 7) to give 24 (61 mg, 53%) as a colourless oil and as a single isomer.  
 IR vmax / cm-1 3368 (N-H), 3292 (O-H), 1694 (C=O), 1739 (C=O); HRMS (ESI): m / z 
311.1584 [M+Na]+, C13H24N2NaO5  requires 311.1583; δH (400 MHz, CDCl3) 6.27 (s, 1H,  
N-H), 5.16 - 4.79 (m, 2H, H-3’, H-2), 4.53 - 4.35 (m, 1H, H-3), 3.55 - 3.23 (m, 2H, H-5), 
2.28 - 2.15 (m, 1H, H-4), 2.09 - 1.87 (m, 1H, H-4), 1.40 (s, 9H, H-8), 1.24 (s, 6H, H-4’);  
δC (101 MHz, CDCl3) 156.5 (C-6), 155.2 (C-2’), 91.5 (C-2), 80.3 (C-7), 72.8 (C-3’), 54.6  
(C-3), 44.9 (C-5), 29.7 (C-4), 28.4 (C-8), 21.9 (C-4’). 
tert-Butyl 3-((isopropoxycarbonyl)amino)-2-oxopyrrolidine-1-carboxylate, 25 
 
To a solution of 24 (135 mg, 0.468 mmol, 1.0 eq.) in DCM (3 mL) was added pyridinium 
chlorochromate (302 mg, 1.40 mmol, 3.0 eq.) and the reaction mixture was stirred at room 
temperature for 12 hours, filtered through Celite® and the solvent was concentrated under 
reduced pressure. The crude residue was chromatographed over silica gel with ethyl acetate / 
hexane mixture (3 : 7) to afford compound 25 (105 mg, 78%) as a colourless oil with an ee of 
86% and an isomer ratio of (93 : 7). 
IR vmax / cm-1 3362 (N-H), 1741 (C=O), 1725 (C=O), 1695 (C=O); HRMS (ESI):  m / z 
309.1429 [M+Na]+, C13H22N2NaO5  requires 309.1427; δH (400 MHz, CDCl3) 6.72 (s, 1H,  
N-H), 4.95 - 4.82 (m, 1H, H-3’), 4.57 - 4.48 (m, 1H, H-3), 3.60 - 3.32 (m, 2H, H-5),  
2.27 - 2.11 (m, 1H, H-4), 2.03 - 1.88 (m, 1H, H-4), 1.37 (s, 9H, H-8), 1.22 (s, 6H, H-4’);  




δC (151 MHz, CDCl3) 171.2 (C-2), 156.8 (C-2’), 153.8 (C-6), 83.7 (C-7), 70.7 (C-3’), 60.5 
(C-3), 36.2 (C-5), 28.5 (C-8), 22.0 (C-4’), 21.1 (C-4); Chiralpak AD hexane / i-propanol  
(1 : 9), flow rate = 1mL / min, λ = 254 nm; Rt (major) = 11.04 min, Rt (minor) = 11.91 min, 
86% ee. 




6.2.3 Synthesis of E1cb products 
General procedure 1 for synthesis of oxazolidinone-hydrazides 
 
To a solution of the aldehyde (1.66 mmol, 1.5 eq.) and L-proline (13.0 mg, 0.11 mmol,  
0.1 eq.) in CH3CN (10 mL) at 0 °C was added dibenzyl azodicarboxylate (330 mg,  
1.11 mmol, 1.0 eq.) and the reaction mixture was left to stir at 0 °C for 30 minutes then at 
room temperature until the complete consumption of DBAD. The reaction mixture was then 
cooled to 0 °C and diluted with methanol (20 mL) followed by sodium borohydride (42 mg, 
1.11 mmol, 1.0 eq.). After 15 minutes, 1 M sodium hydroxide (3.3 mL, 3.32 mmol, 3.0 eq.) 
was added and after an additional 2 hours the resulting mixture was quenched with aqueous 
ammonium chloride (15 mL) and extracted with ethyl acetate (3 x 30 mL). The combined 
organic layers were washed with brine (20 mL) and dried over magnesium sulfate and 
concentrated. The residue was chromatographed on silica gel with an ethyl acetate / hexane 
mixture to afford the product. 
General procedure 2 for synthesis of oxazolidinones 
 
To a solution of the oxazolidinone-hydrazide (0.26 mmol, 1.0 eq.) in dry CH3CN (1 mL) at 
20 °C under nitrogen, was added either Cs2CO3 or K2CO3 as base (0.65 mmol, 2.5 eq.) 
followed by the addition of diethyl bromomalonate (0.09 mL, 0.52 mmol, 2.0 eq.). The 
reaction mixture was left to stir at 20 °C until the starting material was consumed before 
being quenched with aqueous ammonium chloride (5 mL) and extracted with ethyl acetate  
(3 x 10 mL). The combined organic layers were dried over magnesium sulfate and 
concentrated. The residue was chromatographed on silica gel with an ethyl acetate / hexane 
mixture to afford the oxazolidinone product. 




General procedure 3 for synthesis of CBz-protected oxazolidinones 
 
To a solution of oxazolidinone (4.00 mmol, 1.0 eq.) in THF (10 mL) at 0 °C, was added 
sodium hydride (120 mg, 60%, 3.00 mmol, 1.5 eq.) and the reaction was stirred for  
15 minutes at 0 °C. A solution of benzyl chloroformate (0.30 mL, 2.00 mmol, 1.0 eq.) in THF 
(10 mL) was then added dropwise and the reaction mixture was stirred for 3 hours before 
being quenched with aqueous ammonium chloride (10 mL) and extracted with ethyl acetate  
(3 x 20 mL). The combined organic layers were dried over magnesium sulfate and 
concentrated. The crude residue was chromatographed on silica gel with an ethyl acetate / 
hexane (3 : 7) mixture to afford the product. 
(R)-Benzyl (4-octyl-2-oxo-oxazolidin-3-yl)carbamate, 26 
 
Synthesized from decanal (0.31 mL) and according to General procedure 1 gave compound 
26 (356 mg, 92%) as a colourless oil in 90% ee. 
[α]D20 -12.9 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 3323 (N-H), 1740 (2 x C=O); HRMS 
(ESI): m / z 349.2131 [M + H]+,  C19H29N2O4 requires 349.2127; δH  (300 MHz, CDCl3)  
7.36 - 7.22 (m, 5H, Ar), 6.68 (s, 1H, N-H), 5.12 (s, 2H, Bn), 4.25 - 4.05 (m, 1H, H-5),  
4.01 - 3.84 (m, 2H, H-5, H-4), 1.80 - 1.65 (m, 1H, H-6), 1.50 - 1.33 (m, 1H, H-6), 1.29 - 1.06 
(m, 12H, H-7 to H-12), 0.81 (t, J = 6.0 Hz, 3H, H-13); δC (75 MHz, CDCl3) 157.6 (C-2), 
155.4 (C=O), 135.4 (i-Ar), 128.7 (Ar), 128.6 (Ar), 128.3 (Ar), 68.2 (Bn), 67.8 (C-5), 56.9  
(C-4), 31.9 (C-6), 31.8 (C-11), 29.6 (C-8), 29.4 (C-9), 29.2 (C-10), 24.6 (C-7), 22.8 (C-12), 




14.2 (C-13); Chiralpak OD hexane / i-propanol (1 : 9), flow rate = 1mL / min, λ = 256 nm; 




Hydrazide 26 (90.0 mg) according to General procedure 2 with  anhydrous potassium 
carbonate (89.2 mg) for 23 hours gave compound 27 (46.6 mg, 90%) as a colourless oil. 
[α]D20 +29.0 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 3270 (N-H), 1746 (C=O), 1239 (C-O); 
HRMS (ESI): m / z 200.1652 [M + H]+, C11H22NO2 requires 200.1651; δH (400 MHz, CDCl3) 
5.75 (s, 1H, N-H), 4.41 (t, J = 5.3 Hz, 1H, H-5), 3.94 (t, J = 5.3 Hz, 1H, H-5), 3.83 - 3.71 
(pent, J = 5.6 Hz, 1H, H-4), 1.70 - 1.39 (m, 2H, H-6), 1.30 - 1.12 (m, 12H, H-7 to H-12), 0.81 
(t, J = 6.0 Hz, 3H, H-13); δC (75 MHz, CDCl3) 160.2 (C-2), 70.5 (C-5), 67.9 (C-4), 35.4  
(C-6), 31.9 (C-11), 29.5 (C-8), 29.5 (C-9), 29.3 (C-10), 25.6 (C-7), 22.7 (C-12), 14.2 (C-13).  
 
(R)-Benzyl 4-octyl-2-oxo-oxazolidine-3-carboxylate, 27a 
 
Synthesized from 27 (80.0 mg) according to General procedure 3 to afford compound 27a 
(96.0 mg, 72%) as a colourless oil in 83% ee. 
[α]D20 -7.0 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 1792 (C=O), 1725 (C=O); HRMS (ESI):  
m / z 356.1831 [M+Na]+, C19H27NNaO4 requires 356.1838; δH 1H NMR (300 MHz, CDCl3)  
7.37 - 7.19 (m, 5H, Ar-H), 4.58 (s, 2H, Bn), 4.28 - 4.13 (m, 2H, H-5, H-4), 3.99 - 3.90  
(m, 1H, H-5), 2.01 - 1.53 (m, 2H, H-6), 1.26 - 1.11 (m, 12H, H-7 to H-12), 0.80  
(t, J = 6.0 Hz, 3H, H-13); δC (75 MHz, CDCl3) 151.8 (C=O), 151.6 (C-2), 135.6 (i-Ar), 128.9 
(Ar), 128.7 (Ar), 128.5 (Ar), 69.6 (C-5), 66.5 (Bn), 50.9 (C-4), 35.4 (C-6), 31.5 (C-11), 29.6 




(C-8), 29.6 (C-9), 29.3 (C-10), 24.6 (C-7), 22.5 (C-12), 14.3 (C-13); Chiralpak OD hexane / 
i-propanol (1 : 9), flow rate = 0.3 mL / min, λ = 258 nm; Rt(major) = 51.16 min,  
Rt(minor) = 54.96 min. 
(R)-Benzyl (4-methyl-2-oxo-3-oxazolidinyl)carbamate, 28 
 
 
Synthesized from propanal (0.12 mL) according to General procedure 1 to afford compound 
28 (244 mg, 88%) as a white solid in 90% ee. 
[α]D20 -12.7 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 3270 (N-H), 1772 (C=O), 1704 (C=O); 
HRMS (ESI): m / z 251.1036 [M + H]+, C12H15N2O4 requires 251.1032; δH (400 MHz, 
CDCl3) 7.34 - 7.22 (m, 5H, Ar-H), 6.73 (s, 1H, N-H), 5.11 (s, 2H, Bn), 4.41 (t, J = 5.3 Hz, 
1H, H-5), 4.12 - 3.97 (m, 1H, H-4), 3.82 (t, J = 5.3 Hz, 1H, H-5), 1.21 (d, J = 6.0 Hz, 3H,  
H-6); δC (101 MHz, CDCl3) 155.6 (C-2), 154.2 (C=O), 135.4 (i-Ar), 128.8 (Ar), 128.6 (Ar), 
128.4 (Ar), 68.9 (Bn), 68.3 (C-5), 53.0 (C-4), 17.0 (C-6); Chiralpak OD hexane / i-propanol  




To hydrazide 28 (65.0 mg) according to General procedure 2 with anhydrous caesium 
carbonate (212 mg) for 20 hours to afford compound 29 (23.6 mg, 88%) as a colourless solid. 
[α]D20 +22.3 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 3286 (N-H), 1721 (C=O), 1238 (C-O); 
HRMS (ESI): m / z 102.0541 [M + H]+, C4H8NO2 requires 102.0555; δH (300 MHz, CDCl3) 
6.47 (s, 1H, N-H), 4.42 (t, J = 5.0 Hz, 1H, H-5), 4.00 - 3.90 (m, 2H, H-5, H-4), 1.22  




(d, J = 6.0 Hz, 3H, H-6); δC (101 MHz, CDCl3) 160.2 (C-2), 71.7 (C-5), 48.3 (C-4), 20.7  
(C-6). 
(R)-Benzyl 4-methyl-2-oxo-oxazolidine-3-carboxylate, 29a 
 
Synthesized from 29 (40.0 mg) according to General procedure 3 to afford compound 29a 
(73.3 mg, 78%) as a colourless oil in 95% ee. 
[α]D20 -9.0 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1735 (C=O), 1718 (C=O), 1251 (C-O); 
HRMS (ESI): m / z 236.0925 [M + H]+, C12H14NO4 requires 236.0923; δH (300 MHz, CDCl3) 
δ 7.38 – 7.21 (m, 5H, Ar-H), 5.23 (s, 2H, Bn), 4.36 - 4.27 (m, 2H, H-5, H-4), 3.91 - 3.81  
(m, 1H, H-5), 1.34 (d, J = 6.0 Hz, 3H, H-6); δC (75 MHz, CDCl3) δ 151.8 (C=O), 150.8  
(C-2), 135.0 (i-Ar), 128.7 (Ar), 128.6 (Ar), 128.2 (Ar), 68.6 (Bn), 68.6 (C-5), 51.3 (C-4), 19.6 
(C-6); Chiralpak OD hexane / i-propanol (1 : 9), flow rate = 1mL / min, λ = 256 nm; 
Rt(major) = 23.60 min, Rt(minor) = 15.37 min. 
 
(R)-Benzyl (4-isopropyl-2-oxo-3-oxazolidinyl)carbamate, 30 
 
Synthesized from isovaleraldehyde (0.18 mL) according to General procedure 1, to afford 
compound 30 (281 mg, 91%) as a colourless oil in 91% ee. 
[α]D20 -12.5 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 3319 (N-H), 1764 (C=O), 1726 (C=O); 
HRMS (ESI): m / z 279.1345 [M + H]+, C14H19N2O4 requires 279.1345; δH (300 MHz, 
CDCl3) 7.31 - 7.23 (m, 5H, Ar), 6.96 (s, 1H, N-H), 5.09 (s, 2H, Bn), 4.37 - 4.23 (m, 1H, H-5), 
4.09 - 3.80 (m, 2H, H-5, H-4), 2.03 - 1.85 (m, 1H, H-6), 0.91 (t, J = 7.2, 6.6 Hz, 3H, H-7);  




δC (300 MHz, CDCl3) 156.1 (C-2), 155.1 (C=O), 135.3 (i-Ar), 128.6 (Ar), 128.5 (Ar), 128.2 
(Ar), 68.1 (Bn), 64.1(C-4), 60.9 (C-5), 28.5 (C-6), 17.8 (C-7), 15.9 (C-7); Chiralpak OD 
hexane / i-propanol (1 : 9), flow rate = 0.5 mL / min, λ = 258 nm; Rt(major) = 41.41 min, 




To hydrazide 30 (73.0 mg) according to General procedure 2 and anhydrous caesium 
carbonate (214 mg) for 20 hours to afford compound 31 (32.2 mg, 96%) as a colourless oil. 
[α]D20 +22.3 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 3236 (N-H), 1728 (C=O), 1224 (C-O); 
HRMS (ESI): m / z 130.0873 [M + H]+, C6H12NO2 requires 130.0868; δH (300 MHz, CDCl3) 
6.88 (s, 1H, N-H), 4.36 (t, J = 6.0 Hz, 1H, H-5), 4.09 - 3.96  (t, J = 5.0, 1H, H-5), 3.60 - 3.48 
(q, J = 5.3 Hz, 1H, H-4), 1.74 - 1.57 (oct, J = 5.6 Hz, 1H, H-6), 0.88 (d, J = 6.9 Hz, 3H, H-7), 
0.93 (d, J = 6.6 Hz, 3H, H-7); δC (101 MHz, CDCl3) 160.6 (C-2), 68.6 (C-5), 58.4 (C-4), 32.7 
(C-6), 17.9 (C-7), 17.6 (C-7).  
(R)-Benzyl 4-isopropyl-2-oxo-oxazolidine-3-carboxylate, 31a 
 
Synthesized from 31 (51.7 mg) according to General procedure 3 to afford compound 31a 
(84.2 mg, 80%) as a colourless oil in 92% ee. 
[α]D20 -8.0 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 1800 (C=O), 1714 (C=O); HRMS (ESI):  
m / z 286.1048 [M+Na]+, C14H17NNaO4 requires 286.1055; δH (300 MHz, CDCl3)  
7.41 - 7.22 (m, 5H, Ar-H), 5.25 (s, 2H, Bn), 4.24 - 4.05 (m, 3H, H-5, H-4), 2.33 - 2.21  
(m, 1H, H-6), 0.91 (d, J = 4.5 Hz, 3H, H-7), 0.84 (d, J = 6.6 Hz, 3H, H-7); δC (300 MHz, 
CDCl3) 155.8 (C-2), 155.1 (C=O), 136.1 (i-Ar), 128.7 (Ar), 128.6 (Ar), 128.2 (Ar), 67.1 
(Bn), 65.2(C-4), 60.7 (C-5), 28.5 (C-6), 17.2 (C-7), 16.9 (C-7); Chiralpak OD hexane /  




i-propanol (1 : 9), flow rate = 0.5 mL / min, λ = 258 nm; Rt(major) = 26.70 min,  
Rt(minor) = 29.63 min. 
(R)-Benzyl (2-oxo-4-pentyloxazolidin-3-yl)carbamate, 32 
 
Synthesized from heptanal (0.23 mL) according to General procedure 1 to afford compound 
32 (303 mg, 89%) as a colourless oil in 93% ee. 
[α]D20 -12.8 (c = 1.0, EtOAc); IR (neat) vmax / cm-1 3285 (N-H), 1770 (C=O), 1722 (C=O); 
HRMS (ESI): m / z 307.1657 [M + H]+, C16H23N2O4 requires 307.1658; δH (400 MHz, 
CDCl3) 7.33 - 7.22 (m, 5H, Ar-H), 6.74 (s, 1H, N-H), 5.10 (s, 2H, Bn), 4.43 - 4.34 (m, 1H,  
H-5), 4.00 -3.83 (m,  2H, H-5, H-4), 1.76 - 1.36 (m, 2H, H-6), 1.29 - 1.14 (m, 6H, H-7, H-8, 
H-9), 0.91 (t, J = 6.8 Hz, 3H, H-10); δC (75 MHz, CDCl3) 159.2 (C-2), 155.4 (C=O), 136.2  
(i-Ar), 128.9 (Ar), 128.8 (Ar), 127.7 (Ar), 68.3 (Bn) 66.5 (C-5), 54.6 (C-4), 33.3 (C-6), 31.7 
(C-8), 26.1 (C-7), 22.8 (C-9), 14.3 (C-10); Chiralpak OD hexane / i-propanol (1 : 9), flow  





To hydrazide 32 (80.0 mg) according to General procedure 2 with anhydrous potassium 
carbonate (90.2 mg) for 2 days to afford compound 33 (37.4 mg, 76%) as a colourless oil. 
[α]D20 +25.1 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 3308 (N-H), 1742 (C=O), 1233 (C-O); 
HRMS (ESI): m / z 158.1183 [M + H]+ , C8H16NO2 requires 158.1181; δH (300 MHz, CDCl3) 
6.26 (s, 1H, N-H), 4.41 (t, J = 6.3 Hz, 1H, H-5), 3.94 (dd, J = 6.3, 4.8 Hz, 1H, H-5), 3.78 




(pent, J = 5.4 Hz, 1H, H-4), 1.60 - 1.39 (m, 2H, H-6), 1.34 - 1.14 (m, 6H, H-7, H-8, H-9), 
0.82 (t, J = 5.8 Hz, 3H, H-10); δC (75 MHz, CDCl3) 160.1 (C-2), 70.5 (C-5), 52.8 (C-4), 35.4 
(C-6), 31.6 (C-8), 25.0 (C-7), 22.5 (C-9), 14.0 (C-10). 
(R)-Benzyl 2-oxo-4-pentyloxazolidine-3-carboxylate, 33a 
 
Synthesized from 33 (62.9 mg) according to General procedure 3 to afford compound 33a 
(90 mg, 78%) as a colourless oil in 88% ee. 
[α]D20 -9.0 (c = 1.0, EtOAc); IR (neat) νmax / cm-1 1737 (C=O), 1726 (C=O), 1251 (C-O); 
HRMS (ESI): m / z 292.1537 [M + H]+, C16H22NO4 requires 292.1549; δH (300 MHz, CDCl3) 
7.39 - 7.22 (m, 5H, Ar-H), 5.25 (s, 2H, Bn) 5.20 (t, J = 6.3 Hz, 2H, H-5, H-4), 4.02  
(t, J = 6.0 Hz, 1H, H-5), 2.52 - 2.11 (m, 2H, H-6), 2.18 - 1.78  (m, 6H, H-7, H-8, H-9), 0.91 
(t, J = 6.2 Hz, 3H, H-10); δC (75 MHz, CDCl3) 152.8 (C=O), 151.7 (C-2), 135.5 (i-Ar), 128.7 
(Ar), 128.7 (Ar), 128.5 (Ar), 69.5 (C-5), 66.2 (Bn), 51.8 (C-4), 35.6 (C-6), 31.8 (C-8), 23.0 
(C-7), 22.4 (C-9), 14.0 (C-10); Chiralpak OD hexane / i-propanol (1 : 9), flow rate = 0.3 mL / 
min, λ = 258 nm; Rt(major) = 41.29 min, Rt(minor) = 44.52 min. 
 
Benzyl (R)-(4-benzyl-2-oxo-oxazolidin-3-yl)carbamate, 34 
 
  
Synthesized from the corresponding aldehyde (224 mg, 1.66 mmol) using General 
procedure 1 to give 34 (327 mg, 91%) as a colourless oil in 86% ee. 
 
[α]D20 -19.5 (c = 1.0, DCM); IR (neat) νmax / cm-1 1774 (C=O), 1728 (C=O), 1217 (C-O); 
HRMS (ESI): m / z 327.1338 [M + H]+, C18H19N2O4 requires 327.1345; δH (400 MHz, 
CDCl3) 7.53 (br s, 1H, NH), 7.51 - 7.21 (m, 8H, Ar-H), 7.25 - 6.95 (m, 2H, Ar-H), 5.13  




(s, 2H, Bn), 4.37 - 4.18 (m, 2H, H-4, H-5), 4.13 - 3.85 (m, 1H, H-5), 3.28 - 2.95 (m, 1H,  
H-6), 2.91 - 2.73 (m, 1H, H-6); δC (101 MHz, CDCl3) 157.3 (C-2), 155.3 (C=O), 135.3  
(i-Ar), 135.3 (i-Ar), 128.8 (Ar), 128.7 (Ar), 128.4 (Ar), 128.2 (Ar), 128.0 (Ar), 127.0 (Ar), 
67.8 (Bn), 67.0 (C-5), 57.6 (C-4), 37.6 (C-6); Chiralpak OD column hexane / i-propanol   





Synthesised using General procedure 2 with oxazolidinone 34 (80.0 mg, 0.250 mmol) and 
anhydrous potassium carbonate to give 35 (38.0 mg, 84%) after 20 hours as a colourless oil in 
84% ee. 
 
 [α]D20 +51.4 (c = 1.0, DCM); IR (neat) νmax / cm-1 1738 (C=O), 1246 (C-O); HRMS (ESI):   
m / z 178.0864 [M + H]+, C10H12NO2 requires 178.0868; δH (400 MHz, CDCl3) 7.42 - 7.32 
(m, 2H, Ar-H), 7.31 - 7.25 (m, 1H, Ar-H), 7.50 - 7.18 (m, 2H, Ar-H), 6.08 (br s, 1H, NH), 
4.43 (t, J = 5.7 Hz, 1H, H-5), 4.22 - 4.09 (m, 2H, H-4, H-5), 3.09 - 2.69 (m, 2H, H-6); δC (101 
MHz, CDCl3) 159.6 (C-2), 135.9 (i-Ar), 129.0 (Ar), 128.9 (Ar), 127.1 (Ar), 69.5 (C-5), 53.7 
(C-4), 41.3 (C-6); Chiralpak OD column hexane / i-propanol  (1 : 1), flow rate = 1 ml / min,  
λ = 258 nm; Rt(major) = 6.71 min, Rt(minor) = 6.04 min. 
 
Benzyl (R)-(2-oxo-4-(pyridin-3-ylmethyl)oxazolidin-3-yl)carbamate, 36 
 
 
Synthesised from the corresponding aldehyde (328 mg, 1.10 mmol) using General 
procedure 1 to give 36 (450 mg, 87%) as a colourless oil in 95% ee.  
 




[α]D20 -12.8 (c = 1.0, MeOH); IR (neat) νmax / cm-1 1777 (C=O), 1718 (C=O), 1215 (C-O); 
HRMS (ESI): m / z 328.1298 [M + H]+, C17H18N3O4 requires 328.1297; δH (400 MHz, 
CDCl3) 8.47 (d, J = 4.4 Hz, 1H, H-6’), 8.41 (s, 1H, H-2’), 8.34 (br s, 1H, NH), 7.53 - 7.44 
(m, 1H, H-5’), 7.37 - 7.26 (m, 5H, Ar-H), 7.19 (dd, J = 7.6, 4.4 Hz, 1H, H-4’), 5.12 (s, 2H, 
Bn), 4.25 - 4.23 (m, 2H, H-5, H-4), 3.06 - 2.96 (m, 1H, H-5), 3.03 (dd, J = 14.4, 4.6 Hz, 1H, 
H-6), 2.89 - 2.80 (m, 1H, H-6); δC (101 MHz, CDCl3) 157.1 (C-2), 155.6 (C=O), 149.8  
(C-6’), 148.1 (C-2’), 136.9 (C-3’), 135.4 (C-4’), 131.2 (i-Ar), 128.5 (Ar), 128.4 (Ar), 128.1 
(Ar), 123.7 (C-5’), 67.9 (Bn), 66.5 (C-5), 57.1 (C-4), 34.8 (C-6); Chiralpak OD column 
hexane / i-propanol  (4 : 6), flow rate = 1 ml / min, λ = 258 nm; Rt(major) = 8.95 min, 





Synthesised using General procedure 2 with oxazolidinone 36 (80.0 mg, 0.250 mmol) and 
anhydrous cesium carbonate to give 37 (40.0 mg, 90%) after 2 hours as a colourless oil in 
91% ee. 
 
 [α]D20 +18.5 (c = 1.0, MeOH); IR (neat) νmax / cm-1 1771 (C=O), 1726 (C=O), 1222 (C-O); 
HRMS (ESI): m / z 179.0819 [M + H]+, C9H11N2O2 requires 179.0821; δH (400 MHz, CDCl3) 
8.51 (d, J = 4.7 Hz, 1H, H-6’), 8.45 (s, 1H, H-2’), 7.90 - 7.50 (m, 1H, H-5’), 7.30 (dd, J = 7.6,  
4.7 Hz, 1H, H-4’), 6.79 (br s, 1H, NH), 4.42 (t, J = 8.6 Hz, 1H, H-5), 4.43 - 4.13 (m, 1H,  
H-4), 4.10 (dd, J = 8.6, 5.4 Hz, 1H, H-5), 2.98 (s, 1H, H-6), 2.96 (s, 1H, H-6); δC (101 MHz, 
CDCl3) 159.7 (C-2), 151.6 (C-6’), 149.1 (C-2’), 137.8 (C-4’), 133.6 (C-3’), 124.5 (C-5’), 
69.8 (C-5), 53.9 (C-4), 39.0 (C-6); Chiralpak OD column hexane: i-propanol  (4 : 6), flow 









Benzyl (R)-(4-(7-(benzyloxy)ethyl)-2-oxooxazolidin-3-yl)carbamate, 38 
 
 
Synthesized from the corresponding aldehyde (295 mg, 1.10 mmol) using General 
procedure 1 to give 38 (354 mg, 86 %) as a colourless oil in 92% ee.  
 
[α]D20 -8.0 (c = 1.0, CHCl3); IR (neat) νmax / cm-1 1774 (C=O), 1730 (C=O), 1221 (C-O); 
HRMS (ESI): m / z 371.1601 [M + H]+, C20H23N2O5 requires 371.1607; δH (400 MHz, 
CDCl3) 7.25 - 7.40 (m, 10H, Ar-H), 6.94 (br s, 1H, NH), 5.19 (s, 2H, Bn), 4.55 - 4.50 (m, 1H, 
H-7), 4.45 (s, 2H, Bn), 4.22 - 4.00 (m, 2H, H-4, H-7), 3.64 - 3.42 (m, 2H, H-5), 2.06 - 1.81 
(m, 2H, H-6); δC (101 MHz, CDCl3) 157.3 (C-2), 155.3 (C=O), 137.6 (i-Ar), 135.4 (i-Ar), 
128.6 (Ar), 128.5 (Ar), 128.4 (Ar), 128.2 (Ar), 127.9 (Ar), 127.7 (Ar), 73.5 (Bn), 68.0 (Bn), 
68.0 (C-7), 66.3 (C-5), 56.1 (C-4), 31.9 (C-6); Chiralpak OD column hexane / i-propanol   





Synthesised using General procedure 2 with oxazolidinone 38 (200 mg, 0.54 mmol) and 
anhydrous cesium carbonate to give 39 (100 mg, 84%) after 5 hours as a colourless oil in 
87% ee. 
 
[α]D20 +22.0 (c = 1.0, CHCl3); IR (neat) νmax / cm-1 1738 (C=O), 1243 (C-O); HRMS (ESI):  
m / z 222.1119 [M + H]+, C12H16NO3 requires 222.1130; δH (400 MHz, CDCl3) 7.45 - 7.23 
(m, 5H, Ar-H), 6.33 (br s, 1H, NH), 4.50 (s, 2H, Bn), 4.47 - 4.32 (m, 1H, H-7), 4.10 - 4.05 
(m, 2H, H-4, H-7), 3.58 (t, J = 5.7 Hz, 2H, H-5), 2.05 - 1.68 (m, 2H, H-6);  




δC (101 MHz, CDCl3) 137.7 (C-2), 129.8 (i-Ar), 128.6 (Ar), 128.0 (Ar), 127.7 (Ar), 73.5 
(Bn), 70.4 (C-7), 67.6 (C-5), 52.0 (C-4), 35.1 (C-6); Chiralpak OD column hexane /  
i-propanol  (7 : 3), flow rate = 1 ml / min, λ = 258 nm; Rt(major) = 8.62 min,  
Rt(minor) = 9.71 min. 
 
Benzyl (R)-(2-oxo-4-(7-(prop-9-yn-7-yloxy)ethyl)oxazolidin-3-yl)carbamate, 40 
 
 
Synthesized from the corresponding aldehyde (209 mg, 1.10 mmol) using General 
procedure 1 to give 40 (304 mg, 87 %) as a yellow oil in 90% ee.  
 
[α]D20 -12.9 (c = 1.0, CHCl3); IR (neat) νmax / cm-1 1771 (C=O), 1726 (C=O), 1222 (C-O); 
HRMS (ESI): m / z 319.1281 [M + H]+, C16H19N2O5 requires 319.1294; δH (300 MHz, 
CDCl3) 7.46 - 7.29 (m, 5H, Ar-H), 6.80 (br s, 1H, NH), 5.18 (s, 2H, Bn), 4.54 - 4.48 (m, 1H, 
H-7), 4.21 - 4.00 (m, 4H, H-4, H-7, H-8), 3.69 - 3.61 (m 1H, H-5), 3.60 - 3.50 (m, 1H, H-5), 
2.42 (t, J = 2.4 Hz, 1H, H-10), 2.09 - 1.84 (m, 2H, H-8); δC (101 MHz, CDCl3) 157.2 (C-2), 
155.3 (C=O), 135.3 (i-Ar), 128.7 (Ar), 128.5 (Ar), 128.3 (Ar), 79.1 (C-9), 74.9 (C-10), 68.2 
(Bn), 68.0 (C-7), 66.0 (C-5), 58.4 (C-8), 56.1 (C-4), 31.7 (C-6); Chiralpak OD column 
hexane / i-propanol  (1 : 1), flow rate = 0.5 ml / min, λ = 258 nm; Rt(major) = 16.53 min, 
















Synthesised using General procedure 2 with oxazolidinone 40 (100 mg, 0.310 mmol) and 
anhydrous cesium carbonate to give 41 (42.0 mg, 81%) after 4 hours as a colourless oil. 
 
 [α]D20 +21.3 (c = 1.0, DCM); IR (neat) νmax / cm-1 1733 (C=O), 1243 (C-O); HRMS (ESI):  
m / z 170.0809 [M + H]+, C8H12NO3 requires 170.0817; δH (400 MHz, CDCl3) 6.30 (br s, 1H, 
NH), 4.56 - 4.39 (m, 1H, H-7), 4.14 (d, J = 2.4 Hz, 2H, H-8), 4.07 - 3.92 (m, 2H, H-4, H-7), 
3.63 (t, J = 5.7 Hz, 2H, H-5), 2.46 (t, J = 2.4 Hz, 1H, H-10), 1.98 - 1.70 (m, 2H, H-6);  
δC (101 MHz, CDCl3) 159.7 (C-2), 79.3 (C-9), 74.9 (C-10), 70.4 (C-7), 67.1 (C-5), 58.4  
(C-8), 51.6 (C-4), 34.9 (C-6). 
 




To a solution of bis-acetal α-hydrazino alcohol (780 mg, 1.69 mmol, 1.0 eq.) in MeOH  
(15 mL) was added NaOH (5.1 mL, 1M, 5.10 mmol, 3.0 eq.) and the reaction was stirred for 
1 hour at room temperature, when complete consumption of the hydrazine was observed on 
TLC. The reaction was quenched with saturated ammonium chloride solution (20 mL) and 
extracted with ethyl acetate (3 x 20 mL). The organic layers were dried with magnesium 
sulfate and the solvent evaporated in vacuo. The crude residue was then chromatographed on 
silica gel with ethyl acetate / hexane (4 : 6) mixture to give 42 (430 mg, 72% yield) as a 




colourless gum.  The ee could not be determined as none of our HPLC columns could 
separate the enantiomers of this compound – ee is inferred from the ee of the hydrazino 
alcohol starting material as 90%. 
 
[α]D20 -12.2 (c = 0.5, DCM); IR (neat) νmax / cm-1 1780 (C=O), 1740 (C=O), 1236 (C-O), 
1125 (C-O); HRMS (ESI): m / z 375.1529 [M + Na]+, C17H24N2NaO6 requires 375.1532;  
δH (300 MHz, CDCl3) 7.39 - 7.27 (m, 5H, Ar-H), 7.19 (br s, 1H, NH), 5.22 (s, 2H, Bn),  
4.47 - 4.43 (m, 1H, H-5), 4.33 (t, J = 5.4 Hz, 1H, H-9), 4.12 - 3.87 (m, 2H, H-4, H-5), 3.30  
(s, 3H, OMe), 3.29 (s, 3H, OMe), 1.85 - 1.69 (m, 1H, H-6), 1.62 - 1.41 (m, 3H, H-6, H-8) 
1.39 - 1.20 (m, 2H, H-7); δC (101 MHz, CDCl3) 201.3 (C-2), 155.3 (C=O), 135.3 (i-Ar), 
128.5 (Ar), 128.4 (Ar), 128.1 (Ar), 104.1 (C-9), 67.9 (Bn), 67.4 (C-5), 56.6 (C-4), 52.9 





To hydrazide 42 (88.0 mg) and according to General procedure 1 with anhydrous potassium 
carbonate for 48 hours to afford compound 43 (30.5 mg, 86%) as a colourless oil in a 
corrected yield based on a 70% conversion of 42. 
 [α]D20 +27.1 (c = 0.5, DCM); IR (neat) νmax / cm-1 1748 (C=O), 1263 (C-O); HRMS (ESI):  
m / z 226.1052 [M + Na]+, C9H17NNaO4 requires 226.1055; δH (300 MHz, CDCl3) 6.36 (br s, 
1H, NH), 4.45 (t, J = 8.3 Hz, 1H, H-5), 4.33 (t, J = 5.4 Hz, 1H, H-9), 3.99 (dd, J = 8.3,  
6.0 Hz, 1H, H-5), 3.93 - 3.76 (m, 1H, H-4), 3.30 (s, 3H, OMe), 3.29 (s, 3H, OMe),  
1.70 - 1.51 (m, 4H, H-6, H-8), 1.46 - 1.24 (m, 2H, H-7); δC (101 MHz, CDCl3) 157.0 (C-2), 
104.2 (C-9), 80.6 (C-5), 68.8 (C-4), 55.2 (OMe), 50.0 (OMe), 30.3 (C-6), 29.4 (C-8), 17.5  
(C-7). 
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